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THE EFFECT OF SLEEP MEDICATION USE AND POOR SLEEP QUALITY ON RISK OF
FALLS IN COMMUNITY-DWELLING OLDER ADULTS

By Yaena Min, Ph.D.
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Virginia Commonwealth University, 2014

Advisor: Patricia W. Slattum, Pharm.D., Ph.D.
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The work presented in this dissertation focuses on the association between sleep
medication use, poor sleep, and falls in community-dwelling adults 65 years or older. Sleep
complaints and the consumption of medications to aid sleep are common in older adults.
Psychotropic medications, such as sedative hypnotics, are associated with risk of falls in older
adults. However, very few studies have assessed the impact of poor sleep and sleep medication
use on the risk of falls in community-dwelling older adults.
In the first project, a cross-sectional analysis of the Health and Retirement Study (HRS)
2010 data was conducted to determine the prevalence of sleep problems, sleep medication use
and falls; and to evaluate the association between sleep problems, sleep medication use, and falls

in community-dwelling older adults. A multiple logistic model adjusted for covariates was used.
In the sample of community-dwelling older adults, 35.8% had reported a fall and 40.8% had
reported sleep problems in the past two years. Sleep medication use was reported by 20.9% of
the older adults. Older adults who had sleep problems and took sleep medications had a
significantly higher risk of falls compared with older adults who did not have sleep problems and
did not take sleep medications. The other two groups, older adults who had sleep problems and
did not take sleep medications, and those who did not have sleep problems and took sleep
medications also had a significantly greater risk for falls.
The second project was a prospective cohort study of independently-living older adults
from senior congregate housing. The effect of combined poor sleep quality and sleep medication
use on risk of falls was assessed using logistic regression modeling. In this study of 113
community-dwelling older adults, 46.9% had at least one fall, and 62.8% had poor sleep quality.
Sleep medication use was reported by 44.2% of the older adults. Older adults with poor sleep
quality and sleep medication use had a significantly increased risk of falls compared with older
adults with good sleep quality and no sleep medication use. Older adults with good sleep quality
and sleep medication use, and those with poor sleep quality and no sleep medication use did not
have a significantly greater risk for falls.
In conclusion, poor sleep added to sleep medication use significantly increased the risk
of falls in community-dwelling older adults. The research undertaken in this dissertation was the
first to evaluate the associations between poor sleep, use of sleep medications, and falls in
community-dwelling older adults.

Chapter 1
Introduction

1.1 Sleep and Aging
Sleep patterns can be defined as two different physiologic states: REM (rapid eye movement)
sleep and NREM (non-rapid eye movement) sleep. NREM is divided into stage 1, the lightest
stage of sleep, to stage 4, deep sleep or slow-wave sleep. Sleep typically cycles between REM
and NREM approximately every 90 minutes after an individual falls asleep until waking up and
there is more REM sleep in the second half of the night.1 In 2007, the American Academy of
Sleep Medicine redefined the NREM stages as N1, N2, and N3, with N3 combining the
traditional sleep stages 3 and 4 together and REM as stage R.1,2
There are quantitative and qualitative changes in sleep (e.g., increased sleep fragmentation,
earlier awakenings and reduced slow wave sleep [SWS]) that occur with increasing age.3
Increased lighter stages of sleep, decreased slow-wave and REM sleep, and decreased total sleep
time, sleep quality and sleep efficiency are other age-dependent changes in sleep frequently
reported in older adults.1,4 The biggest change in sleep patterns in older adults is the repeated and
frequent interruption of sleep by long periods of wakefulness which could be because of the
changes in circadian rhythm and homeostatic regulation of sleep occurring with age.1,5,6 There
are also changes in the neuroendocrine system with aging that alter sleep duration and sleepwake cycles in older adults.7 However, age itself is not a sole cause for poor sleep in older
adults.8 Decreased ability to maintain sleep in older adults is also commonly secondary to
medical and psychiatric comorbidities and medications use to treat these disorders.8,9 In addition,
1

insomnia, obstructive sleep apnea (OSA), and restless legs syndrome (RLS) are primary sleep
disorders that can exacerbate sleep difficulties in older adults.1 Besides these factors, changes in
social patterns (e.g., retirement) have been identified to be associated with sleep quality in older
adults.10

1.2 Poor Sleep Quality in Older Adults
Sleep complaints are common in older adults.11,12 Approximately 50% of independently
living older adults aged 65 years or older in the United States reported a sleep complaint.11
Moreover, older adults are often dissatisfied with the quality of their sleep.13
Sleep quality is an important clinical construct since complaints about sleep quality are
common and it is a common symptom of many sleep and medical disorders.14 According to
Buysse who developed a validated tool to measure sleep quality, sleep quality is defined as
“quantitative aspects of sleep such as sleep duration, sleep latency, or number of arousals, as well
as more purely subjective aspects, such as depth or restfulness of sleep”.14 Studies have used the
terms sleep problems, sleep disturbance, difficulty sleeping, poor sleep, or poor sleep quality
interchangeably. Sleep problems primarily include nighttime sleep problems (e.g., trouble falling
asleep, trouble with waking during the night, trouble waking and getting up in the morning, and
trouble waking too early and not being able to fall back to sleep).15 Daytime sleepiness and poor
quality of sleep are also considered sleep problems.15
Poor sleep quality results in significant mortality and morbidity in elderly individuals.
Studies have reported that older adults with sleep disturbances had poorer quality of life and
higher rates of depression and anxiety compared with those with no sleep disturbances.3,9,16
2

Cognitive impairment was shown in older adults with sleeping difficulties compared with those
with no difficulties.17 Additionally, poor sleep quality is related to decreased psychomotor
function.18 Overall, the consequences of poor sleep are deleterious in older adults.

Difficulty sustaining attention
and a slowed response time

Associated with
comorbidities

Decreased performance

Poor Sleep

Increased risk of falls

Impairments in memory and
concentration

Higher mortality

Figure 1.2 Consequences of Poor Sleep

1.3 Nonpharmacologic Treatments to Aid Sleep
There are nonpharmacologic interventions to aid sleep such as cognitive behavioral therapy
(CBT).19,20 CBT includes stimulus control therapy, sleep restriction, relaxation therapies, and
cognitive therapies. Sleep hygiene measures are recommended to those who report having sleep
disturbances. It is recommended that behavioral therapies and education on good sleep hygiene
be included in treatment plans for disordered sleep in older adults.8 The following are some
interventions of good sleep hygiene.1,20
(1) Keep a regular sleep schedule by having stable bedtimes and rising times.
(2) Avoid sleep-fragmenting substances (e.g., caffeine, cigarettes, and alcohol).
3

(3) Go to bed only when sleepy.
(4) Maintain the bedroom restful and comfortable.
(5) Avoid napping after 2 pm and heavy exercise within 2 hours of bedtime.
(6) Increase activity level in the afternoon or early evening by exercising or walking.
(7) Sleep only in the bedroom and avoid activities in the bedroom that wake you up.

1.4 Medications Prescribed for or Used by Older Adults to Aid Sleep
The consumption of medications to aid sleep (e.g., sedative hypnotics) is common in older
adults.21 Because of decreased satisfying or refreshing sleep, older adults use a
disproportionately high percentage of prescription drugs compared with other age groups to treat
these complaints.22 The 2003 National Sleep Foundation poll found that about 20% of older
adults used some kind of sleep aid including prescription medications, over-the-counter sleep aid,
and alcohol to help with sleep at least a few nights per week: 11% reported taking a prescription
medication, 6% took an over-the-counter medication, and 6% used alcohol.23,24
Pharmacological treatments that are commonly prescribed to older adults with disturbed
sleep include prescription medications (e.g., benzodiazepines, benzodiazepine receptor agonists,
melatonin receptor agonists, antidepressants, antipsychotics and antiepileptics), nonprescription
sleep aids (e.g.,antihistamines), herbal products/dietary supplements, and alcohol.20,22 The first
orexin receptor antagonist, suvorexant, was recently approved by the U.S. Food and Drug
Administration (FDA) for treating difficulty in falling and staying asleep.25
Prescription medications:
Benzodiazepines: Benzodiazepines (e.g., triazolam, temazepam, flurazepam, alprazolam,
4

clonazepam, and lorazepam) promote sleep onset. These medications enhance the action of γ aminobutyric acid (GABA) which causes sedation.26 In 2006, benzodiazepines were the most
commonly prescribed medications to treat sleep disorders in older adults.27 Adverse events
include hangover effects, impaired psychomotor performance and cognitive function.18,22
Benzodiazepine receptor agonists: Benzodiazepine receptor agonists include zaleplon, zolpidem,
and eszopiclone. These nonbenzodiazepines have similar effects to benzodiazepines by binding
to specific subtypes of the GABA-A receptor.28 Zolpidem reduces sleep latency, improves total
sleep duration, and reduces night-time awakenings.29 Common adverse events during short term
treatment (i.e., 10 days) are drowsiness, dizziness, and diarrhea, and during the long-term
treatments (28-35 days), dizziness and drugged feelings are frequent.19 Zaleplon has a fast onset
of action and the shortest duration of action among the benzodiazepine receptor agonists.19
Because of its short half-life, it has less morning hangover; however, it also has increased risk of
rebound insomnia.19 Eszopiclone is a stereoisomer of zopiclone. It is used when patients have
difficulty falling asleep or difficulty maintaining sleep. It has been shown to reduce the time to
sleep onset and enhance the quality and depth of sleep compared with placebo.30 The most
common adverse events of eszopiclone in older adults are headache, unpleasant taste,
somnolence, and dysepepsia.31
Melatonin receptor agonist: Ramelteon is a selective melatonin receptor agonist with affinity for
MT1 and MT2 receptors.22 It received FDA approval for patients with difficulty falling asleep.32
It has low risk of side effects,22 including rebound insomnia and withdrawal effects.32 Ramelteon
did not show adverse next-day psychomotor or cognitive effects in older adults.33
Antidepressants: Antidepressants are also used to treat disturbed sleep in older adults.22 Tricyclic
antidepressants (e.g., amitriptyline and doxepin), and heterocyclic antidepressants (e.g.,
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trazodone and mirtazapine) are the most commonly used sedating antidepressants.34 These
medications have sedating effect due to their anticholinergic and antihistaminergic effects.34
Although commonly used, antidepressants antihistaminergic, antiadrenergic and anticholinergic
side effects.35 Trazodone has side effects of daytime drowsiness and dizziness that could be
detrimental to older adults leading to accidents.22
Antipsychotics: Antipsychotic medications (e.g., quetiapine and olanzapine) are often used off
label for sleep because of sedating side effects.22,34 Antipsychotics are mostly used in individuals
with serious psychiatric disorders.22,34 Side effects can be disturbance of continuity of sleep
resulting from nocturnal myoclonus.36 Although antipsychotics can be beneficial in patients with
psychiatric disorders, use may be harmful for healthy populations.37,38
Antiepileptics: Antiepileptics (e.g., gabapentin and tiagabine) are increasingly used to treat poor
sleep in the elderly.22,37 Tiagabine is a selective GABA reuptake inhibitor that enhances sleep.37
Gabapentin reduces neurotransmission in glutamate and norepinephrine systems that regulates
wake-promoting activity.37 However, the effects on other sleep properties vary among patients
after taking this drug.37 Common antiepileptic side effects are ataxia, diplopia, and nausea.26

Nonprescription medications:
Antihistamines: Diphenhydramine and doxylamine are the most common antihistamines used for
sleep in older adults.20,22 Antihistamines can cause cognitive impairment, daytime drowsiness,
and anticholinergic side effects (e.g., dry mouth, constipation, and blurred vision).22 Most of all,
there is insufficient data to show clinical effectiveness on sleep in older adults.20,22

6

Herbal products/Dietary supplements:
Other pharmacologic treatments taken to aid sleep include herbal sleep products and
dietary supplements.20,22 Several herbal products are available for treating sleep problems:
valerian, chamomile, kava-kava, and passion flower.22 There is lack of evidence or mixed
evidence to support the safety and efficacy of most herbal sleep aids in older adults.20 Melatonin
is a hormone related to the sleep-wake cycle in humans. Melatonin supplementation is used to
treat sleep problems related to jet-lag or shift work.19 Side effects experienced by patients when
taking melatonin include fatigue, headache, dizziness, and increased irritability.19

Alcohol:
Alcohol is widely used by older adults to aid sleep; however, it has negative effects on
sleep.20 Alcohol can disrupt sleep by decreasing latency of sleep onset and REM sleep and
increasing SWS.20 During the second half of the night, REM sleep rebound and sleep
fragmentation may occur.39

Conclusion:
Poor sleep quality is common among older adults. Of the consequences of poor sleep
quality, the risk of falls is the focus of this study. It is reasonable to expect that poor sleep quality
might be a risk factor for falls since lack of sleep may cause daytime sleepiness, cognitive
deficits, and reduced psychomotor performance that may lead to increased risk of falls.40 In
addition, older adults who have poor sleep could experience falls secondary to increased activity
7

during the night in darkness.15
Older adults use various medications and treatments to aid sleep. However, there are few
randomized controlled studies that assess the efficacy and safety of these medications in older
adults compared with younger adults.22 Even though guidelines recommend short-term and lowdose use with short half-life sedative hypnotics in older adults, these medications are often used
for extended periods.41 The main adverse effects of pharmacologic treatments are daytime
sleepiness, confusion and cognitive impairment, dizziness, and impairment of coordination and
psychomotor functions, which may further relate to falls in older adults.35
The next section will provide a literature review on falls, the association between sleep
medications and falls, and the association between poor sleep and falls in community-dwelling
older adults. A review of literature will show some gaps on the combined effect of sleep
medication use and poor sleep on the risk of falls.
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Chapter 2
Literature Review

The purpose of this section is to review the literature to determine the prevalence of falls in
older adults, and to assess the relationship between medications to aid sleep and falls, and
between poor sleep and falls in older adults. This will help us to better understand what is
already known about the association between poor sleep, sleep medication use, and falls in older
adults.

2.1 Falls in Community-Dwelling Older Adults
Falls in older adults:
Falls are among the most common and serious problems faced by older adults. About 30%
of community-dwelling adults aged 65 years or above experience a fall per year and about 15%
of them fall two or more times per year.42,43 In addition, 50% of adults aged 80 years and older
fall at least once a year.44,45 Falls cause both fatal and nonfatal injuries. Falls are associated with
reduced functioning, loss of independence and premature nursing home admissions.46,47
Specifically, falls are the primary reason for 85% of all injury-related hospital admissions48 and
for more than 40% of nursing home admissions.49 According to the Centers for Disease Control
and Prevention about 2.4 million older adults were treated in hospital emergency departments
(ED) for nonfatal injuries from unintentional falls, resulting in more than 655,000 of these
patients being hospitalized in 2012.50 The death rates because of falls have risen over the past
9

decade with approximately 22,901 older adults dying from unintentional fall injuries in 2011.50
Unsurprisingly, falls increase the cost of care. The total direct medical cost due to fall-related
care for the non-institutionalized elderly population was $7.8 billion in 2002 and increased up to
$19 billion in 2006 including institutionalized older adults.51,52 A total cost of fall-related injuries
in older adults is projected to be $47 billion in 2010 dollars by the year of 2020.53 The cost is
even higher if indirect costs associated with loss of productivity from falls in this population are
considered.51

Definition of falls:
Various definitions of falls have been proposed. The World Health Organization (WHO)
defines a fall as “an event which results in a person coming to rest inadvertently on the ground
floor or other lower level”.54 The Prevention of Falls Network Europe (ProFaNE) group defined
a fall as “an unexpected event in which the participant comes to rest on the ground, floor, or
lower level”.55 Other similar definitions are provided by the Kellogg International Working
Group and Frailty and Injuries Cooperative Studies of Intervention Techniques (FICSIT).56 The
variations in the definition of falls may cause comparability issues among the studies.

Risk factors for falls:
The risk of falls is multifactorial46 and risk can be categorized as modifiable and nonmodifiable factors.57 Impaired vision, impaired balance and mobility, orthostatic hypotension,
fear of falling, mood disorder, osteoporosis, incontinence, and polypharmacy are considered as
modifiable risk factors, while age, gender, and race are non-modifiable risk factors.57,58 Previous
falls, medications, and reduced strength, gait and balance are most strongly associated with the
10

risk of falls.59 A meta-analysis that included prospective studies assessing the risk factors in
community-dwelling older adults was conducted.60 It found that a 5-year increase in age, being
female, living alone, having a history of falls, having a physical disability, experiencing
disability in instrumental activities of daily life (IADL) and using a walking aid are associated
with increased risk of falling.60 Cognitive impairment, depression, history of stroke, urinary
incontinence, rheumatic disease, vertigo, diabetes, pain, Parkinson’s Disease, and fear of falling
are other factors associated with falls in older adults.60 Increment of one medical condition and
self-perceived health status are also associated with falls. Additionally, gait problems, vision and
hearing impairment are shown to increase the risk of falls.60

Assessment of falls:
Various fall assessment measures are used in different settings (e.g., outpatient clinic,
inpatient or home).61 First, clinician-rated scales are formalized questionnaires conducted by
clinicians who use a semi-structured or structured interview to collect data. Self-report
assessments mainly rely on a patient’s recall of the events. Single task assessments are a more
targeted tool to assess balance or gait disturbances that increases the fall risk. Lastly, multipletask performance measures, a more comprehensive assessment of falls risk, can be used and
provide more detailed information.
According to the American Geriatrics Society (AGS) and the British Geriatrics Society (BGS)
Guideline for Prevention of Falls in Older Persons, multifactorial fall risk assessment is
recommended for older adults who present with a fall or have gait and balance problems.46
Multifactorial fall risk assessment that AGS/BGS guidelines included are: history of falls,
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medications, gait, balance and mobility, visual acuity, other neurological impairments, muscle
strength, heart rate and rhythm, postural hypotension, feet and footwear, and environmental
hazards.46

2.2 Medications to Aid Sleep and Falls in Community-Dwelling Older Adults
Several studies have investigated the relationship between sedative hypnotics and falls in the
adult population. A meta-analysis that included sedative hypnotics (i.e., benzodiazepines,
zolpidem, zaleplon, zopiclone, antihistamines, and diphenhydramine) reported that the subjects
using these medications had a higher incidence of falls.21 The risk of psychomotor adverse events
in those who take sedative hypnotics was higher than a placebo group but it was not significantly
different than placebo (OR=2.61; 95% CI=1.12-6.09).21 Another meta-analysis that evaluated the
impact of nine medication classes on falls in older adults found that sedatives and hypnotics,
(OR=1.47; 95% CI=1.35-1.62), antidepressants (OR=1.68; 95% CI=1.47-1.91), and
benzodiazepines (OR=1.57; 95% CI=1.43-1.72) were significantly associated with falls.62 A
recent meta-analysis by Bloch and colleagues found antidepressants (OR=1.44; 95% CI=1.311.59), benzodiazepines (OR=1.31; 95% CI=1.16-1.47), and hypnotics (OR=1.40; 95% CI=1.241.58) were significantly related to any falls in adults aged more than 60 years old.63 These results
were similar to the previous meta-analysis.62 Overall, these studies suggest that some
medications frequently used to aid sleep have an association with falls in older adults.
Several mechanisms have been proposed to explain the relationship between falls and use of
sedative hypnotics. Some of the adverse effects of sedative hypnotics (i.e., daytime sedation,
drowsiness, and dizziness) may lead to falls.64–67 Sedative hypnotics can also impair posture,
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reaction time, coordination, protective responses during falls, and cardiovascular reflexes that
normally prevent orthostatic hypotension.64–67 The following section will describe the available
literature regarding the relationship between the use of each type of medication used to aid sleep
and the risk of falls in community-dwelling older adults.

Prescription medications:
Benzodiazepines: Benzodiazepines can impair motor function and coordination in older adults
that may result in falls and consequent fractures.22 There is consistent evidence of an increased
risk of falls associated with benzodiazepines use in older adults.62,68,69 A prospective cohort study
that included community-dwelling women aged 65 years and older were followed incident falls
for 1 year. It found that participants using benzodiazepines (OR=1.51; 95% CI=1.14-2.01) are at
increased risk of falls after adjusting for multiple confounders.69 This study clearly defined a fall
as “falling all the way down to the floor or ground, or falling and hitting an object like a chair or
stair”.69 Additionally, an observational study that included community-dwelling frail older adults
defined the fall event as “ a sudden loss of balance causing the contact of any part of the body
above the feet with the floor” and it had to happen within 90 days of the evaluation.70 It found
that those who take benzodiazepines had an increased risk for falling (OR=1.36; 95% CI=1.081.71) after adjusting for potential confounders.70 The authors also found a high risk of falls in
patients using long elimination half-life benzodiazepines (OR=1.45; 95%CI=1.00-2.19) and
short-elimination half-life benzodiazepines (OR=1.32; 95% CI=1.02-1.72).70 Lastly, a
prospective nested case-control study that examined the association between benzodiazepine use
and injurious falls found that in subjects who were 80 years and older, the usage of
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benzodiazepines was significantly associated with injurious falls (OR=2.22; 95% CI=1.44-3.43),
while those under 80 years old had a non-significant increase.71 Injurious falls were defined as
“falls causing hospitalization, fractures, head trauma or death”.71
Benzodiazepine receptor agonists: The relationship between the risk of falls and benzodiazepine
receptor agonists was assessed in community-dwelling older adults, but it was not found to be
significant.70 On the contrary, a retrospective study in inpatient older adults showed that
zolpidem (OR=2.63; 95% CI=1.04-5.43) was significantly associated with increased risk of
falls.72 In addition, a retrospective study that included hospitalized older adults concluded that
zolpidem was a significant risk factor for falls (OR= 2.59; 95% CI=1.16-5.81) after adjusting for
calcium channel antagonists and meprobamate, that are other medications significantly
associated with a risk of falls.73 Benzodiazepine receptor agonists were found to have negative
effects on balance, gait, and equilibrium which can lead to falls.67
Melatonin receptor agonist: Ramelteon is reported to improve latency to persistent sleep and
total sleep time in adults with transient and chronic insomnia and in older adults with chronic
insomnia; however, there is no evidence of next-day residual cognitive and psychomotor
effects.74,75 No study has been conducted to assess the relationship between falls and ramelteon.
Antidepressants: Antidepressants may cause falls through sedation, impaired reaction time and
balance, sleep problems resulting in daytime drowsiness and increased nocturia, orthostatic
hypotension, disorders of cardiac rhythm, or a movement disorder.76 Tricyclic antidepressants
(TCAs) and selective serotonin reuptake inhibitors (SSRIs) may have a significant association
with falling via postural hypotension caused by anticholinergic side effects, extrapyramidal
effects and sedation.77,78 A prospective study with community-dwelling older adults, found that
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antidepressant use (OR=1.54; 95% CI=1.14-2.07) was associated with an increased risk of
experiencing falls.69 Another population-based prospective longitudinal study that included
adults aged 70 years or older evaluated the association between depression, antidepressants, and
falls.79 Fall was defined as “unintentionally coming to rest on the floor, ground, or other lower
surface in this study.79 Antidepressant use significantly increased the risk of falls including
indoor and outdoor falls when considering depression in the relationship (IRR=incidence rate
ratio=1.50; 95% CI=1.11-2.03).79 Lastly, a study that included men aged 60 to 75 years old found
that antidepressants were significantly associated with at least one fall (OR=2.80; 95% CI=1.94.1) after adjusting for age, body mass index, current smoking status, and alcohol.80 The data was
from a 10-year prospective population-based study. It further analyzed and found that SSRIs
(OR=3.10; 95% CI=2.0-5.0) and TCAs (OR=2.20; 95% CI=1.0-4.7) are associated with falling
in fallers with at least one fall.80 In contrast, another study with community-dwelling older adults
did not find any significant association between antidepressants and falls.70
Antipsychotics: Typical and atypical antipsychotic medications are related to an increased risk of
falls62 that may be via extrapyramidal side effects, sedation or orthostatic hypotension.77 An
observational study with community-dwelling older adults found a higher risk of falling in those
who use typical antipsychotic drugs (OR=1.49; 95% CI=1.10-2.51) and atypical antipsychotic
drugs (OR=1.45; 95% CI=1.00-2.11) after adjusting for age, sex, activities of daily living (ADL)
score, cognitive performance scale score, depression, comorbidity, number of medications, foot
problems, gait problems, fear of falling and wandering.70 In contrast, another study found that
older men on antipsychotics were not found to have an increased risk of falls.80 However, this
study may not have had enough participants who took antipsychotics resulting in insufficient
power to detect an association.
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Antiepileptics: Antiepileptics may be associated with falls secondary to common adverse effects
(e.g., sedation, dizziness, and unsteady gait).69,81 A prospective study that was conducted in
women aged 50 to 79 years old showed that users of antiepileptics had an increased risk of two
or more falls (HR=1.62; 95% CI=1.50-1.74) after adjusting for multiple confounders compared
with non-users.81

Nonprescription medications:
Antihistamines: Diphenhydramine and doxylamine can cause cognitive and psychomotor
functioning impairment,34,35 that may be associated with risk of falls in older adults.82 Studies
have emphasized that antihistamines should be used in caution in older adults34,35 because of
daytime drowsiness and anticholinergic effects.20,22

Herbal products/Dietary supplements:
A randomized placebo-controlled trial investigated the effect of olfactory stimulation
with lavender on fall prevention in elderly individuals in nursing homes.83 Interestingly, the
group treated with lavender patches had fewer fallers (HR=0.57; 95% CI=0.34-0.95) and a lower
incidence rate of falls (1.04 per person-year) compared with the placebo group. The authors
speculated that lavender may have a soothing effect to reduce agitation and stabilizing effects on
balance to prevent falls. No other studies conducted in community-dwelling older adults to
evaluate the association between herbal products or dietary supplements and falls were identified.
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Alcohol:
Alcohol can potentially raise the risk of falls by adversely affecting reaction time,
judgment, or balance in older adults,84 however, alcohol’s association with falls is less clear in
this population.85 A prospective cohort study with community-dwelling older men found that
light alcohol drinkers (≤13 drinks/week) had a lower risk of two or more falls in the first year of
follow-up compared with those who did not drink alcohol (RR=0.77; 95% CI=0.65-0.92).86 This
suggested a protective association. However, the study found that moderate to heavy drinking
(≥14 drinks/week) was not associated with a risk of falls.86 Another prospective cohort study in
community-dwelling older adults found no difference between non-drinker and light-to-moderate
drinkers (≤14 drinks/week) on risk of falls, but found a significant increase risk of falls in heavy
drinkers (14 or more) during the follow-up of 4 years (OR=1.25; 95% CI=1.03-1.52) compared
with non-drinkers after adjusting for multiple confounders.87 Similarly, another study showed
that high alcohol consumption (500+g/month) was significantly associated with injurious falls in
women aged 60 years or older (OR=2.13; 95% CI= 1.05-4.32).88 Overall, these studies were
conducted in community-dwelling older adults; however, findings about the association between
alcohol consumption and falls in this population are inconsistent.89

Conclusion:
There were several limitations of the studies that were included in this review. First,
systematic literature reviews and meta-analyses had consistent results that the use of sedative
hypnotics, benzodiazepines, and antidepressants increase the likelihood of falls in older adults.
However, there was conflicting results or no results with nonprescription medications, herbals
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and alcohol on the association with falls in community-dwelling older adults. These reviewed
studies did not specifically mention which medications were included in each drug classification,
thus it is difficult to assess whether the majority of medications are frequently used to aid sleep.
In addition, methods of ascertaining medication use were different among the studies. In
some studies participants were asked to bring the medications that were used, while others
collected information directly from general practitioners or through medical records. Studies
have defined the outcome of falls with different definitions, and most studies did not even report
how they defined the outcome. Additionally, studies had different methods to document falls
(e.g., using diaries, post cards, or phone calls). These differences in the studies make it more
difficult to directly compare the results across studies.
Most of all, confounding by indication in the association between sleep medication use and
falls can occur but the indications for these medications were not clearly mentioned. Yet given
that these medications are frequently used for sleep and that the results of systematic literature
reviews and meta-analyses are consistent with each other, it is important to consider that sleep
medications could be the main risk factors for falls.

2.3 Poor Sleep and Falls in Community-Dwelling Older Adults
One important and potential risk factor for falls that has not been investigated in most studies
is poor sleep in older adults.15 To date, there has been no systematic review integrating studies
that evaluated the association between sleep problems and risk of falls in older adults. Therefore,
we conducted a systematic review of the literature to investigate the association between sleep
problems and falls in community-dwelling adults aged 65 years or older. This will help to
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elucidate whether sleep problems are a significant risk factor for falls in independently living
older adults.

2.3.1 Methods:
The review was conducted based on the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines.90

Eligibility Criteria:
Studies were included if they met the following criteria:
1) Studies that evaluated poor sleep or other types of sleep problems as an independent predictor
variable and the occurrence or number of falls or the risk of falls as an outcome variable.
2) Studies that included community dwelling adults aged 65 years old or older. Communitydwelling older adults are non-institutionalized older adults who live independently.
3) Studies that were published in English.
4) Studies that were published in a peer-reviewed journal.

Studies were excluded if they met the following criteria:
1) Studies that included only specific sub-populations of older adults with specific health
conditions (e.g., Parkinson’s diseases or dementia).
2) Studies that were reviews, commentaries, case-reports, case-studies or newsletters.

Information sources:
A systematic search of studies from major databases was conducted from inception until
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December 31, 2013. The search was applied to Pubmed/MEDLINE (1946-2013), CINAHL
(1937-2013), and PsycINFO (1887-2013) to identify relevant studies. Restrictions were applied
to limit the search to studies in English. The last search was conducted in January 30, 2014. In
addition, the grey literature was searched to find non-conventional publications through The New
York Academy of Medicine (NYAM) (1992-2013).

Systematic search strategy:
MeSH terms and text words of sleep problems and falls were used: ("Sleep"[Mesh] OR
"Sleep Disorders"[Mesh] OR “Sleep”[tw] OR “sleep disorders”[tw]) AND ("Accidental
Falls"[Mesh] OR “Falls”[tw]). Similar search terms were used for CINAHL and PsycINFO.
Quick search of the database for the grey literature through NYAM with a combination of
“healthy aging fall” and “prevention fall” was conducted. See appendix A for the search
algorithm.

Study selection:
Eligibility assessment was performed in a standardized manner by the first author. In the
first phase of the review, the reviewer independently reviewed the titles and the keywords of the
articles. Studies that included the terms “sleep” or “falls” or “older adults/elderly” within a title
or keyword were retained for further review of the abstracts. In the second phase of the review,
abstracts were reviewed to determine whether the full texts should be reviewed. In the last phase
of the review, full texts were read and if there was any doubt after reviewing the full texts, the
second author determined whether the articles would be included in the final inventory of studies.
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Data collection:
Data extraction was conducted by one reviewer but reviewed multiple times to reduce
error. The data included study design, year of publication, location, study population, study
duration, sample size, measurement of sleep problems (a predictor variable), measurement of
falls (an outcome variable), adjusted covariates, and association statistics (e.g., odds ratio with 95%
confidence interval and p-value).

Methodological quality assessment:
The Newcastle-Ottawa Scale (NOS) was used to assess the methodological quality of the
studies. NOS is recommended by the Cochrane Collaboration as one of the most useful tools to
evaluate non-randomized studies and it is simple to apply.91 The scale is used to judge the
selection of the groups, the comparability of the groups, and the ascertainment of the exposure
and the outcome of interest.91 The NOS was originally developed to assess only case-control and
cohort studies.92 Since ten out of fifteen of the reviewed studies were cross-sectional studies, an
adapted form of NOS for cross-sectional studies developed by Herzog et al. was applied.93 The
maximum score is 9 for cohort studies and 10 for cross-sectional studies. The scores were
predicted to be low and similar across the studies because most studies have assessed the
predictor and outcome variables by self-report. Results are shown in Table 2.2 and 2.3.

Summary measures:
To evaluate the association between sleep problems and falls, association statistics were
reported as well as 95% confidence intervals. Adjusted association was the main statistic
reported, but various confounding variables were adjusted across the studies.
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2.3.2 Results:
Study selection:
Figure 2.1 shows the flow diagram of studies included in the systematic review. A total
of 490 studies were retrieved from PubMed, 200 studies from CINAHL, and 17 from PsycInFO.
An additional seven studies were retrieved from the NYAM search of grey literature. One
hundred and thirty-two studies were identified as duplicates. After the titles, key words, and
abstracts were reviewed, 37 articles were included in the full text reviews. Twenty-two studies
were excluded with reasons at the full text reviews: studies that were reviews, commentaries, or
case reports, studies that did not assess an outcome of falls or the association between sleep
problems and falls, and studies that only reported results for the general population with absence
of a separate analysis for older adults. A total of 15 original research studies were included in
this review.
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Identification

Additional records identified
through grey literature report
(n= 7)

Records after duplicates removed
(n= 582)

Eligibility

Records screened
(n= 582)

Full-text articles assessed
for eligibility
(n= 37)

Included

Screening

Records identified through database
searching
(n=707)

Studies included in
qualitative synthesis
(n= 15)

Records excluded
(n= 545)

Full-text articles excluded,
with reasons
(n= 22)
newsletter, review
n=9
general population
n=1
case report
n=3
commentary
n=1
no association assessed n=8

Figure 2.1 PRISMA Flow Diagram for Search Strategy90
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Study characteristics:
Out of fifteen studies, ten studies were cross-sectional studies while five studies were
prospective cohort studies. Thirteen studies included only community-dwelling older adults,
while the other two studies included both institutionalized and community-dwelling older adults.
The studies were conducted primarily in the U.S. and Australia. The predictor variable “sleep
problems” was primarily collected by self-report or validated questionnaires. The most common
questionnaire used was the Epworth Sleepiness Scale (ESS) which is a measure of daytime
sleepiness. The outcome variable “falls” was collected by self-report either as a fall in the past 6
or 12 months. Table 2.1 provides a description of each study. The findings are organized by type
of sleep problems evaluated.

Nighttime sleep problems and falls:
Several studies investigated whether nighttime sleep problems have an association with
falls in older adults. Brassington et al.15 examined whether nighttime sleep problems are risk
factors for falls. The investigators assessed habitual nighttime sleep difficulties by rating on a
self-reported scale. Compared with non-fallers, fallers had problems of nighttime sleep (i.e.,
falling asleep at night, waking up during the night, waking up in the morning and waking up too
early in the morning and not being able to fall asleep again). After adjusting for covariates
including use of prescription medication, difficulty falling asleep at night (OR=1.53; 95% CI
1.04-2.24), waking up during the night (OR=1.91; 95% CI=1.44-2.54), waking up in the morning
(OR=2.13; 95% CI=1.28-3.55) and waking up too early in the morning and not being able to fall
asleep again (OR=1.64; 95% CI=1.11-2.42) were significantly associated with the occurrence of
falls.15 In addition, nighttime sleep problems, except for waking up too early in the morning and
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not being able to fall asleep again were significantly associated with the number of falls. Most
nighttime sleep difficulties had a significant association with the occurrence and the number of
falls while controlling for other covariates. However, this study was a cross-sectional study and
validated questionnaires were not used to assess the sleep problems. The study by Helbig et al.94
evaluated the relationship between sleep disturbances (i.e., trouble falling asleep and trouble
staying asleep, and falls). The odds of falls were higher in older adults who had trouble staying
asleep and trouble falling asleep. However, these sleep problems were significantly associated
with falls only in adults over 75 years of age.94 This might be because of differences in the level
of frailty between younger old (i.e., between 65 and 75 years old), and older and oldest old (i.e.,
more than 75 years of age).
In contrast to these findings, a cross-sectional study by Teo et al.95 found no significant
increase of risk of falls due to the same nighttime sleep problems after adjusting for covariates.
This was in agreement with a prospective study by Byles et al.96 that showed that none of the
nighttime sleeping problems were associated with falls after adjusting for covariates. Although
both studies by Brassington et al.15 and Teo et al.95 evaluated the same categories of nighttime
sleep problems and used the same scale of 1 (never) to 5 (always), they had conflicting findings.
The study by Byles et al.96 asked about different aspects of nighttime sleep problems and used a
different scale of responses. Byles et al. defined sleep problems as waking up in early hours,
lying awake for most of the night, taking a long time to get to sleep, sleeping badly at night, and
having worry that keeps them awake at night. Unfortunately, detailed results of the association
between each nighttime sleep component and falls were not reported.96
Differences among the studies may contribute to the inconsistent findings. Some studies
only included community-dwelling older women,95,96 while other studies included community-
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dwelling older adults of both genders and with a broader range of age.15,94 Furthermore, some
studies adjusted for more variables, including medical status or medications, that could be related
to falls to account for the effect of the confounders in an attempt to find the relationship between
sleep problems and falls.15,94

Sleep quality and falls:
There were three studies that specifically evaluated the relationship between sleep
quality and falls. The study by Hill et al.97 determined whether sleep disturbances contribute to
the risk of falling. The survey was conducted by interviews with older adults living in residential
aged care and an internet-based survey was conducted in independent-living older adults. The
same questions about sleep were asked to both groups, but only the results for internet study
participants were included in this review, because those living in residential aged care facilities
are semi-independent. Sleep characteristics evaluated were quality of sleep, duration of sleep,
daytime alertness, napping during the daytime and nocturnal awakenings. The study found no
association between any of the sleep characteristics and falls in internet response participants, but
investigators were able to identify that those who had no sleep problems (14%) were less likely
to fall (OR=0.3; 95% CI=0.1-0.9).97 However, it is possible that internet respondents may not
represent the general community-dwelling older adult population. A study by St George et al.,10
which specifically asked about sleep quality in 169 residents from self-care units and assistedcare hostels, did not find an association between sleep quality and falls in either group. The
results of the study were not reported separately for self-care units and assisted-care hostels
participants, so there could have been different results in independent-living older adults alone.10
Both studies did not define poor sleep quality and did not use a validated questionnaire to assess
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sleep quality.10,97 The study by Endeshaw98 was the only study that used the validated Pittsburgh
Sleep Quality Index (PSQI) to measure sleep quality. This study included approximately 250
participants and reported no significant relationship between poor sleep quality and falls.
However, numerical results were not presented to support this conclusion. Interestingly, the
study found that individuals with nocturia with difficulty going back to sleep were more likely to
have falls (OR=4.32; 95% CI=1.51-12.42) than those without difficulty going back to sleep
(OR=2.95; 95% CI=1.08-8.81).98 Based on the studies that evaluated sleep quality and falls, poor
sleep quality was not shown to be associated with the risk of falls, but this may be because of a
lack of a consistent definition of sleep quality and the use of validated tools to measure it.

Daytime sleepiness and falls:
Daytime sleepiness, which is a feeling of being sleepy or struggling to stay awake in the
daytime, was assessed in most of the selected studies. The study by Teo et al.95 showed that
daytime sleepiness increased the risk of falls twofold after adjusting for covariates of fall-related
risk factors (OR=2.05; 95% CI=1.21-3.49). This study used the Epworth Sleepiness Scale (ESS)
to measure daytime sleepiness, and the fallers scored 12.4 on the ESS compared with non-fallers
who scored 5.7. An ESS score greater than 10 indicates abnormal daytime sleepiness. On the
other hand, Brassington et al.15 found that daytime sleepiness was significantly associated with
the number of falls but not with the occurrence of falls. However, the investigators did not use a
validated questionnaire to evaluate daytime sleepiness. Additionally, studies by Hill et al.97 and
Helbig et al.94 found that daytime sleepiness was not significantly associated with falls in older
adults. Significant results were not seen in adults age 75 years or above in the study conducted
by Helbig et al.94
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Two95,97 out of the four studies evaluating daytime sleepiness as a risk factor used a
validated questionnaire, the ESS, to measure daytime sleepiness in older adults.15,94,95,97 Despite
using the same measure, varying results were documented. The investigators Teo et al.95 and Hill
et al.97 used the ESS to evaluate daytime sleepiness, while Brassington et al.15 and Helbig et al.94
asked a question about daytime sleepiness. Since the study by Hill et al.97 did not provide
detailed results for internet study participants, we cannot further investigate the differences
between the studies by Teo et al.95 and Hill et al.97 Thus, it is difficult to conclude whether
daytime sleepiness is significantly related to falls. To further investigate the relationship, more
studies using a validated tool to measure daytime sleepiness are needed.

Sleep duration and falls:
Other sleep problems in older adults include short or fragmented sleep duration. Of the
nine studies evaluating the risk of falls among individuals with varying duration of sleep,
two99,100 were prospective cohort studies and seven were cross-sectional studies.10,15,94,97,101–103
The study by Mesas et al.101 found that older adults who slept 11 hours or more per 24 hours had
an increased risk of recurrent falls (i.e., two falls or more) compared with those who slept 7-8
hours (OR=2.75; 95% CI=1.32-5.62) even after adjusting for covariates. However, the
association between sleeping less than 5 hours and falls was not significant after adjusting for
covariates. A similar trend was seen between sleep duration and falls (i.e., one fall or more) in
older adults. After stratifying by age and sex, sleeping 11 hours or more (OR=2.34; 95%
CI=1.17-4.68) and sleeping less than 5 hours (OR=2.15; 95% CI=1.20-3.87) were significantly
associated with falls only in adults older than 75 years of age.101 In addition, women who had 11
hours or more of sleep had a significant risk of falls (OR=3.89; 95% CI=1.74-8.69) compared
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with men.101 This was the only study that stratified by age and sex that showed a higher risk of
falls among adults aged 75 years or older and women aged 65 years or older. The study by
Helbig et al.94 categorized the duration of sleep as less than or equal to 5, 6, 7-8, 9, and greater
than or equal to10 hours and found that only individuals without dizziness who slept 9 hours a
day were more likely to fall (OR=1.47; 95% CI=1.03-2.11) after adjusting for all covariates. In
the unstratified analysis, significant associations with other durations of sleep were found in a
basic model that adjusted for age and sex but was not found in full models that adjusted for many
covariates.
A third study by Kuo et al.102 showed that there was a significant association between
sleep duration of less than 5 hours and falls in women after adjusting for covariates (OR=5.98;
95% CI=1.72-20.85). The association between short sleep duration and falls was also significant
after controlling for confounders in women who do not use any psychotropic medications
(OR=9.04, 95%CI=1.44-56.84).102 However, this association was not found in men. Similarly, St
George et al.10 found that older adults who slept less than 6 hours were three time more likely to
have falls after adjusting for age, gender, psychotropic medication use, accommodation, activity
and health status (OR=3.13; 95% CI=1.33-7.37). However, this study included older adults
residing in an assisted living facility who may have a different profile of health characteristics
and the investigators did not report the results separately for those who live independently.
Among the studies, Stone et al.100 objectively measured sleep characteristics by using
sleep actinography and found that sleeping less than 5 hours was significantly associated with
recurrent falls compared with sleeping 7 to 8 hours (OR=1.52; 95% CI=1.03-2.24), however,
there was no relationship between long sleep (8 or more hours) and risk of falls.100 On the other
hand, another study by Stone et al.99 tested the relationship between self-reported sleep duration
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and falls and showed that there was an increased likelihood of having two or more falls in
women who reported sleeping more than 10 hours per 24 hours compared with those who
reported sleeping between 8 and 9 hours (OR=1.50; 95% CI=1.14-1.97).99 However, this was
noted only in an age-adjusted model; a significant relationship was not found in the multivariate
adjusted model. In addition, Brassington et al.15 and Hill et al.97 did not find a significant
association between sleeping less than 8 hours a day with the occurrence and number of falls.
Lastly, a study by Grundstrom et al.103 analyzed adults aged 85 years and above to
evaluate the risk of falls in this aged population. One of the risk factors studied was days of
perceived insufficient sleep, which represents the days when participants did not feel they got
enough sleep or rest in the past 30 days. The days were categorized as 0, 1-7, 8-14, 15-22, and
23-30 days, but insufficient sleep over the last 30 days was not associated with a higher risk of
falls in the past 3 months (OR=1.01; 95% CI=1.00-1.02).
Overall, these results suggest that older adults experiencing short duration of sleep (less
than 5 hours of sleep) are at risk for experiencing more falls than those who sleep normal hours
(between 7-8 hours). Long duration of sleep (more than 9 hours) as a risk factor remains
controversial. Studies by Stone et al.99,100 were the only studies that collected data prospectively,
but they only included Caucasian/ White participants. Other studies were all cross-sectional in
design so causality cannot be explained in the association. Except for the study by Stone et al.100
sleep duration was subjectively measured that might result in bias. Moreover, studies used
different categorizations of the duration of sleep, which contributes to variability and makes
drawing conclusions difficult.
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Napping and falls:
There is a correlation between the two sleep factors of sleep duration and napping in that
people who sleep less at night also have longer naps during the day. Four studies investigated in
detail whether napping during the day is a risk factor for falls.10,15,99,100 St George et al.10 found
that napping more than 30 minutes significantly increases the risk of multiple falls (OR=3.10; 95%
CI= 1.30-7.42) even after controlling for covariates. Residents of an assisted-care facility had
more hours of napping than residents living independently. However, since results for these two
categories of participants were not reported separately, the results for independent living older
adults are not available.
The results were in agreement with Stone et al.99 in which women who took daily naps
were more likely to have two or more falls during the following year (OR=1.32; 95% CI=1.031.69). The authors also found that women who nap 3 hours or more per week have a significant
increased risk of recurrent falls compared with those taking naps less than 3 hours per week
(OR=1.33; 95% CI=1.10-1.60).99 The second study by Stone et al.100 measured naps using
actigraphy and did not find any relationship between the risk of falls and napping. This might be
attributed to using a different method of measuring napping. Actigraphy measures intentional
and unintentional naps which could have measured more napping hours compared to measuring
by self-report. Finally, a study by Brassington et al.15 showed that napping during the day was a
significant predictor of the number of falls even though it was not associated with the occurrence
of falls. However, daytime napping was self-reported and the magnitude of the effect was small
(b=0.17; 95% CI=0.01-0.34).15
Three10,15,99 out of four studies found that napping during the day is significantly
associated with falls.10,15,99,100 Studies reported that older adults napping more than 30 minutes a
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day or napping three hours or more per week have a significant risk of falling. The only study
that did not find any association with falls used actinography to measure naps.100 Considering the
consistency of the results that used self-report as a measure of napping, older adults reporting
daytime napping have a significantly increased risk of falls.

Sleep disorders:
Few studies have investigated the relationship between specific sleep disorders and falls.
Gassmann et al.104 evaluated potential predictors of occasional and recurrent falls in communitydwelling older adults in Germany. Diagnosis with a sleep disorder was found to be a significant
predictor among occasional fallers with only one fall (OR=2.69; 95% CI=1.58-4.6) and recurrent
fallers who had two or more falls (OR=2.96; 95% CI=1.44-6.06) during the past 6 months
compared with non-fallers.104 However, there was no further description or definition of sleep
disorder provided, thus the effect of specific type or severity of sleep disorder could not be
assessed.
A study by Kaushik et al.105 evaluated whether sleep apnea is related to falls in older
adults. Sleep apnea was assessed by self-reported diagnosis. Other sleep-related variables that
were evaluated were snoring, whether participants had been told that they snore, witnessed apnea,
whether participants had been told that they stopped breathing during sleep, and daytime
sleepiness assessed by ESS. Sleep apnea was found to be significantly associated with two or
more falls during the previous 12 months (OR=2.23; 95% CI=1.11-4.47) after adjusting for
covariates.105 No other sleep-related variables were found to be related to falls, however,
quantitative results were not reported for these other variables.

32

Lastly, Cirillo and Wallace106 evaluated whether restless legs syndrome is associated with
functional limitations among American elders. Based on the Diagnostic and Statistical Manual of
Mental Disorders, Fifth Edition (DSM-5) criteria, restless legs syndrome is classified as a sleepwake disorder. It is a tingling feeling in your legs and is often worse at night or when inactive.
Two or more falls in the last 2 years were significantly associated with higher prevalence of
restless legs syndrome (OR=2.63; 95% CI=1.49-4.66) but not with only falling once.106
Specific sleep disorders (e.g., sleep apnea, restless legs syndrome) were found to be
significantly related to falls. Sleep apnea was defined by self-reported diagnosis and doubled the
risk of experiencing a fall. In addition, people who fell two or more times had a higher
prevalence ratio of restless legs syndrome. Odds ratio is an approximation to the prevalence ratio.
The prevalence ratio of 2.63 for falling twice or more means that those with frequent falls had a
2.63 times higher prevalence of restless legs syndrome than those who did not fall. Sleep
symptoms (e.g., problems with early awakening) were adjusted to focus specifically on the
impact of restless legs syndrome on the risk of falls.
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Table 2.1 Summary of Included Studies
Authors

Setting

Study population
and sample size
Communitydwelling older
adults
(971 female), age
range 64-99 years
old

Predictor variables

Brassington et
al.15 (2000)

U.S.

Byles et al.96
(2003)

Australia

Communitydwelling older
adults (10,430
female),
age range 70-75
years old

Cirillo and
Wallace106
(2012)

U.S.

Communitydwelling older
adults, 1008
participants (578
female), age range
50-80 years old

Endeshaw98
(2009)

U.S.

Communitydwelling older
adults, 123
participants (63
female), mean age
75.6 years old

Nighttime sleep difficulties
(falling asleep at night,
waking up during the night,
waking up in the morning,
waking up too early in the
morning and not being able
to fall asleep again) and
alertness during the day
(daytime sleepiness, nap
during the day, and less than
8 hours of sleep)

Outcomes

Adjusted variables

Occurrence and
frequency of
falls in the past
12 months

Age, gender, use of prescription
medication, difficulty walking, having
greater than one chronic condition,
vision impairment, and depression

Sleeping difficulty (waking
up in early hours, lying awake
for most of the night, taking a
long time to get to sleep,
sleeping badly at night, and
having a worry that keep
awake at night)
Restless legs syndrome

Occurrence of
falls in the past
12 months

Use of sleeping medications,
symptoms, acute conditions, age, and
life events

Occurrence of
one or more
than one fall the
last 2 years

Sleep quality and daytime
sleepiness

Occurrence of
one or more
than one fall in
the past 6
month

Age, gender, income, current drinking
status, body mass index (BMI), pain,
number of chronic medications used,
out of pocket medical expenses,
frequency of doctors’ visits in last 2
years, health limits ability to work,
associated sleep problems
Age, gender, number of medications,
cardiovascular/cerebrovascular disease
status, use of sedative hypnotics, and
nocturia status
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Grundstrom et
al.103 (2012)

U.S.

Gassmann et al.
104
(2009)

Germany

Helbig et al.94
(2013)

Germany

Kaushik et
al.105
(2007)

Australia

Kuo et al.102
(2009)

Taiwan

Communitydwelling older
adults, 12,684
participants (9036
female), age 8595+ years old
Communitydwelling older
adults, 622
participants (297
female), age range
65-90 years old
Communitydwelling older
adults
3875 participants
(1998 female), age
range 65-93 years
old
Communitydwelling older
adults, 1,952
people, age range
60-97 years old

Perceived insufficient sleep
(number of days in the past
30 days when participants did
not get enough sleep or rest)

Occurrence of
falls and fallrelated injury in
the past 3
months

Sleep disorder

Occurrence of
falls during the
6 months

Sleep habits (trouble falling
asleep, difficulty staying
asleep), daytime sleepiness,
and sleep duration (≤5, 6, 7-8,
9, ≥10 hours)

Occurrence of
falls in the
previous 12
months

Sleep apnea, other sleeprelated variables (snoring and
daytime sleepiness)

Occurrence of
falls in the past
one year

Communitydwelling older
adults, 256
participants (135
female), mean age
72.2 years old

Sleep duration (less than 5
hours, 5-7.9 hours, and 8 or
more hours)

Occurrence
falls in the past
12 months
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Age, gender, race, marital status,
general health, activity limitation due
to health problem, health problem
requiring assistive devices, smoking,
consume of alcohol, BMI, diabetes,
history of stroke
Only bivariate associations were
assessed

Age, sex, education level, leisure time,
physical activity, multimorbidity, eye
and neurological disease, depression
and/or anxiety, psychotropic or
antihypertensive medication, risk for
malnutrition, disability, hearing
impairment, and dizziness
Age, female gender, history of stroke,
presence of arthritis, visual
impairment, use of sedative,
phenothiazine, and antidepressant,
depression and mental state
Age, educational level, living alone,
smoking, alcohol consumption,
comorbid conditions and dieases
(diabetes, hypertension, heart disease,
arthritis, chronic lung disease,
depressive symptom, and central
obesity), use of medications
(antihypertensives, antidepressants,
sedatives, and antipsychotics), lowextremity function summary score, and
cognitive impairment

Hill et al.97
(2007)

Australia

Mesas et al.101
(2010)

Spain

St. George et
al.10 (2009)

Australia

150 hostel older
adults (99
women), age
range 81±8 and
150 communitydwelling older
adults (85 female),
age range70±5
years old
Communitydwelling older
adults,
1542 older adults
(892 female),
mean age 77.4±6.3
years old

Daytime sleepiness, sleep
quality, restfulness of sleep,
duration of sleep, number of
nocturnal awakenings

Occurrence of
falls in the past
12 months

Age, depression, mobility (Timed Get
Up and Go scores, and Snellen chart
score) , pain, use of walking aids, use
of diuretics

Sleep duration (≤5, 6, 7-8, 9,
10, ≥11 hours per day)

Occurrence and
number of falls
in the past 12
months

Older adults
440 from self-care
units and
132 from assisted
care-hostels, age
range 62-95 years
old

Sleep quality, sleep duration,
restful sleep, waking
condition, napping frequency,
napping duration

Occurrence of
falls in the past
12 months

Age, gender, education level, size of
municipality, leisure-time physical
activity, smoking, alcohol and coffee
consumption, BMI, social ties,
perceived health, Short Form 36 (SF36) physical and mental summary,
limitation in IADL, urine loss,
depression, hypertension, diabetes,
cancer, myocardial infarction, stroke,
heart failure, dementia, Parkinson’s
disease, osteoporosis, snoring,
nocturia, hip fracture or prosthesis,
visual and hearing impairment,
walking device, knee pain, sleeping
pill consumption, difficulty falling
asleep, frequent awakening during the
night, early awakening, unrested in the
morning, and daytime sleepiness
Age, gender, psychotropic medication
use, accommodation type, activity and
health status
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Stone et al.100
(2008)

U.S.

Communitydwelling older
women, 2978
female, age range
84±4 years old

TST, sleep efficiency, wake
time after sleep onset,
napping (termed daytime
inactivity)

Occurrence of
falls in the past
12 months

Age, race, BMI, depression, exercise,
limitation in IADL, medical
conditions, possible dementia, and use
of benzodiazepines, antidepressants,
and antipsychotics

Stone et al.99
(2006)

U.S.

Communitydwelling older
women, 8,101
female, age range
77±5 years old

Daily napping, number of
hours of napping per week,
and napping at least 3 hours
per week, total daily duration
of sleep

Occurrence of
falls in past 12
months

Age, BMI, history of at least one
medical condition, walk for exercise,
alcohol consumption, depression,
cognitive impairment, use of
benzodiazepines and estrogen, and
urinary incontinence

Teo et al.95
(2006)

Australia

Communitydwelling older
women, 782
female, age range
75-86 years old

Nighttime sleep disturbance
(trouble falling asleep, with
waking during the night,
waking and getting up in the
morning, waking too early
and not being able to fall back
asleep) and daytime
sleepiness

Occurrence of
one or more
than one fall in
the past 12
months

Age, Central Nervous System (CNS)
drugs, Cardiovascular System (CVS)
drugs, and nocturia
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Table 2.2 Methodological Quality of Included Cohort Studies by Newcastle Ottawa Scale92
Study
(first
author)

Study
design

Byles et
al.96
(2003)
Gassmann
et al.104
(2009)
St George
et al.10
(2009)
Stone et
al.100
(2008)
Stone et
al.99
(2006)

Prospective
cohort
(3 years)
Prospective
cohort
(6 months)
Prospective
cohort
(1 year)
Prospective
cohort
(1 year)
Prospective
cohort
(1 year)

Selection
Representativeness
of the sample

+

Selection of
the nonintervention
cohort

Comparability

Ascertainment
of the
exposure

+

Based on
design or
analysis

Assessment
of outcome

++

+

+

Demonstration
that outcome
was not present
at the start

+

+

++

+

+

+
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Followup cohort

+

+

+

+

+

Outcome
Followup period

+

+

+

++

+

+

++

+

+

Table 2.3 Methodological Quality of Included Cross-Sectional Studies by Newcastle Ottawa Scale93
Study
(first
author)
Brassington
et al.15
(2000)
Cirillo &
Wallace106
(2012)
Endeshaw98
(2009)
Grundstrom
et al.103
(2012)
Helbig et
al.94
(2013)
Kaushik et
al.105 (2007)
Kuo et al.102
(2009)
Hill et al.97
(2007)
Mesas et
al.101 (2010)
Teo et al.95
(2006)

Study
design

Selection

Comparability

Outcome

Representativeness
of the sample

Sample
size

Nonrespondents

Ascertainment
of the exposure

Based on design or
analysis

Assessment
of outcome

Statistical test

Crosssectional

+

+

+

+

++

+

+

Crosssectional

+

+

++

+

+

Crosssectional
Crosssectional

+

++

++

+

+

+

+

+

++

+

+

Crosssectional

+

+

+

++

+

+

Crosssectional
Crosssectional
Crosssectional
Crosssectional
Crosssectional

+

++

+

+

+

++

+

+

++

++

+

+

+

++

+

+

++

++

+

+

+
+
+

+

+

+
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2.3.3 Discussion:
To our knowledge, this is the first systematic review to focus on the association
between sleep problems and falls in community-dwelling older adults. Most of the studies
that were included in the review explored this relationship as their primary objective. Based
on this review, problems of nighttime sleep (e.g., trouble staying asleep, trouble falling asleep,
short or long sleep duration, and napping) appear to be highly associated with the risk of falls.
However, it is difficult to draw conclusions about causality because most of the studies were
cross-sectional.
Thirteen out of fifteen studies accounted for medication use in assessing sleep
problems and falls in older adults. Most studies mentioned specific classes or types of
medications that were accounted for while only two adjusted for the prescription medication
use or the number of medications used. Five studies clearly mentioned adjusting for sedative
medications.96,98,101,102,105 Two studies adjusted for psychotropic medications10,94 which one of
them clearly considered sedative hypnotics94 and one study95 adjusted for medications acting
on the central nervous system (CNS). Two studies adjusted for benzodiazepines.99,100
However, the magnitude of the fall risk associated with sleep problems with or without
adjusting for these medications was not possible to compare in most of the studies.
Additionally, other various covariates (e.g., chronic conditions) were adjusted for in the
studies which changed the unadjusted associations. For example, studies by Stone et al.99 and
Helbig et al.94 found that long duration of sleep increased the risk of fall in basic models, but
significance was lost after accounting for various risk factors for falls. This may be because
the mechanism of association is mediated by other risk factors for falls.
The association between sleep disturbances and falls can be explained by various
mechanisms. Sleep disturbances may cause daytime sleepiness, impaired cognitive
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performance, balance and gait problems, and slower response time.23,40,107 In addition, it was
frequently mentioned that poor sleep may cause cognitive dysfunction with memory and
concentration problems.17,97,108,109 All of these impairments are reported to be caused by poor
sleep that may increase the likelihood of falls. Results of the current systematic review
suggest that some types of sleep problems are significantly related to falls in older adults.
The NOS was used to assess the methodological quality of the included studies. The
scores for the cross-sectional studies that were included in this review ranged from five to
eight while cohort studies ranged from three to seven. Lower scores indicate that there are
deficiencies in the methodology of the studies.93 Most studies included samples that are
representative of the population of interest; however, did not provide justification of the
sample size. In addition, most studies controlled for basic demographic variables (e.g., age
and gender) in addition to comorbidities and number of medications used that are associated
with risk of falls. However, the covariates that were adjusted for varied across the studies and
the numbers ranged from four to more than ten variables that might result in comparability
issues among the studies.
All studies except for one100 used subjective measures to assess the sleep problems
which can result in information bias. Some studies used validated measures to assess sleep
problems but most studies did not use a validated tool. These trials reported the questions that
were used to identify sleep problems. Additionally, the outcome of falls was primarily
collected for the previous 12 months and evaluated by self-report. Since the report of the
outcome depended solely on the participants’ recall, recall bias is highly possible because of
inaccurate memory of the past. It is imperative to accurately define the outcome of interest
but there were variations in the definitions of falls across studies that were included.
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This systematic review has potential limitations. First, most studies included were
cross-sectional in design. Out of the fifteen studies that were included in the review, only five
studies were prospective cohort studies. Causal relationship cannot be established in crosssectional studies. Second, two studies in the review included both institutionalized and noninstitutionalized elderly populations and reported the combined or less descriptive results. If
the studies had evaluated both populations separately, it would have added to our
understanding of the relationship between sleep problems and falls specifically for
community-dwelling older adults. Third, there is a measurement bias in evaluating sleep
problems and falls. Most studies had their own questionnaires to collect sleep problems that
results in heterogeneity in assessments. Lastly, some studies did not provide a definition of
sleep problems and falls that were being examined. Consensus in defining the exposure and
outcome will facilitate interpretation of the results of future studies.
In the future, there is a need to have more well-designed prospective cohort studies in
this population to investigate the relationship between various types of sleep problems and
falls. In addition, inclusion of a comparison group without any sleep problems would lead to
a stronger conclusion about the association. Sleep problems were measured by self-reports in
most of the studies. It has been reported that self-reports of certain aspects of sleep are not
significantly different from polysomnographic estimates.110 However, more studies are
needed that measure sleep objectively or at least use validated measurement tools that better
assess the exposure and facilitate comparisons among the studies. The same is true for the
reporting of falls. There is a need to assess falls by more than one method to confirm each
outcome. It may also be helpful to assess the risk more accurately if a detailed evaluation of
the falls that participants experience is conducted.
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2.3.4 Conclusion:
In conclusion, this review provides insights that sleep problems are an important
consideration in older adults with respect to the outcome of falls. Some sleep problems (e.g.,
problems of nighttime sleep, short or long duration of sleep, and napping) appear to be highly
associated with the outcome of falls. Older adults are at risk of falling and many suffer from
sleep problems. It is important to consider that sleep problems, rather than medications to aid
sleep, could be an important risk factor for falling in older adults. Sleep problems could also
add to the risk for falls associated with sedative medications. This review demonstrated that
some sleep problems can significantly increase the likelihood of falls in older adults. Future
research is needed to establish which specific aspects of sleep problems can cause falls, so
that health care professionals can include appropriate assessments and interventions when
managing fall risk in patients with sleep problems.
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Chapter 3
Objective and Specific Aims

3.1 Hypothesis
Based on the literature review, a hypothesis was formulated. Since most studies did not
consider poor sleep as a potential confounder when assessing the association between sleep
medication use and falls in older adults, it is of interest to understand whether sleep
medications that are used for poor sleep contribute more than poor sleep to the risk of falls. It
is reasonable to expect that poor sleep might be a risk factor for falls. Thus, it was
hypothesized that there is a relationship between poor sleep, medications to aid sleep, and
falls in older adults aged 65 years or older. This hypothesis would be addressed in this
research.

3.2 Objective
The objective of this study is to assess the association between the poor sleep,
medications prescribed for or used by patients to aid sleep, and a combination of these two
factors, on the risk of falls in community-dwelling adults aged 65 years or older.

3.3 Specific Aims
Specific Aims for Project 1: The Association between Sleep Problems, Sleep Medications and
Falls in Community-Dwelling Older Adults: Results from the Health and Retirement Study
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2010
I. To determine the prevalence of sleep problems, sleep medication use, and falls in
community-dwelling older adults
II. To evaluate the association between sleep problems, sleep medication use, and falls in
older adults
III. To evaluate the association between sleep problems, sleep medication use, and injurious
falls in older adults
IV. To evaluate the association between sleep problems, sleep medication use, and recurrent
falls in older adults

Specific Aim for Project 2: The Effect of Sleep Medication Use and Poor Sleep Quality on
Risk of Falls in Community-Dwelling Older Adults
To evaluate the association between poor sleep quality, sleep medication use, and falls in
community-dwelling older adults

3.4 Significance
Falls are a common and serious problem in older adults. There is a high percentage of
older people falling and suffering from the consequences of falls. Sleep problems are also
common and detrimental in this population. Poor sleep quality can cause excessive daytime
sleepiness, cognitive dysfunction, and decreased psychomotor performance, which all can
increase the risk of falls. Moreover, the consumption of medications for sleep is high in this
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population, including use of psychotropic agents and sedative hypnotics that are reported to
be strong risk factors for falls. Since most studies did not consider poor sleep quality as a
potential confounder when assessing the relationship between medications used for sleep and
falls in older adults, it is still unclear whether the condition of poor sleep is problematic or the
treatments that are used to aid sleep are responsible for the risk of falls. To my knowledge
only one study has assessed the association with insomnia, sedative hypnotics, and the
combined effect of these two variables on the risk of falls in institutionalized older adults.40
This study will help us understand medication-associated risk when treating sleep
problems in community-dwelling older adults. This study will enable us to compare those
who have poor sleep but are not taking any medications to treat it, those who take
medications and have good sleep, and those who take medications but still have poor sleep
compared to those with good sleep and no use of sleep medications. This will help us
understand whether treating the sleep problems with sleep medications leads to having a
lower or higher risk of falls than not treating sleep problems. Overall, the results of this study
will assist clinicians in making informed decisions when treating sleep problems in older
adults.
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Chapter 4
The Association between Sleep Problems, Sleep Medications, and Falls in CommunityDwelling Older Adults: Results from the Health and Retirement Study 2010

In this chapter a study evaluating the association between sleep problems, sleep
medications, and falls in community-dwelling older adults using the Health and Retirement
Study (HRS) will be discussed. The risk of injurious falls and recurrent falls along with risk
of any falls will be investigated. In addition, the prevalence of sleep problems, sleep
medication use, and falls in this population will be documented.

4.1 Abstract
Introduction: Studies have shown that the use of psychotropic medications such as sedative
hypnotics have a significant association with risk of falls in older adults. However, very few
studies have assessed the impact of poor sleep and sleep medication use on the risk of falls
among community-dwelling older adults.
Objective: The objectives for this study were: 1) to determine the prevalence of sleep
problems, sleep medication use and falls; and 2) to evaluate if sleep problems and sleep
medication use was associated with risk of falls, injurious falls, and recurrent falls in
community-dwelling adults aged 65 years or older.
Methods: The study population comprised a nationally representative sample of noninstitutionalized adults aged 65 years or older participating in the 2010 Health and Retirement
Study. The proportion of adults reporting sleep problems, sleep medication use, and fall were
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calculated. The effect of combined impact of sleep problems and sleep medications on risk of
falls was assessed using logistic regression modeling and controlling for covariates.
Statistical analyses were performed using SAS 9.4 statistical software.
Results: Among 9,939 community-dwelling older adults, 36.4% had reported a fall and 40.9%
had reported sleep problems in the past two years. Sleep medication use was reported by 21.1%
of the adults. Older adults who did not have sleep problems and took sleep medications
(OR=1.24; 95% CI= 1.06-1.45) had a significant risk of falls, compared with older adults
who did not have sleep problems and did not take sleep medications. Older adults who had
sleep problems and did not take sleep medications (OR=1.16; 95% CI= 1.02-1.32) and those
who had sleep problems and took sleep medications (OR=1.20; 95% CI= 1.02-1.42) had a
significant risk of falls, compared with older adults who did not have sleep problems and did
not take sleep medications. All the groups of older adults had an increased risk of injurious
falls compared to the reference group. Older adults who had sleep problem and did not take
sleep medications (OR=1.27; 95% CI=1.10-1.47) and those who had sleep problems and took
sleep medications (OR=1.40; 95% CI= 1.17-1.68) had a significant risk of recurrent falls
compared to the reference group.
Conclusion: Sleep problems, sleep medication use, and occurrence of falls are common
among community-dwelling older adults. Consistent with previous literature, sleep
medication use was associated with risk of falls among these adults. Additionally, those who
did not report having sleep problems but who took sleep medications had the highest risk of
falls compared with other groups of participants. Further prospective studies are needed to
confirm these observed findings in community-dwelling older adults.
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4.2 Introduction
One-third of community-dwelling adults aged 65 years and older experience a fall per
year.42 Falls can cause both fatal and nonfatal injuries. Falls are also associated with reduced
functioning and earlier admission to nursing homes.46,47 In 2010, approximately 21,700 of
older adults died from unintentional fall injuries.50 Age, gender, and race are non-modifiable
risk factors for falls while modifiable risk factors include acute illness, incontinence, fear of
falling, gait and mobility impairment, and visual/sensory deficits.57,58 Additionally,
medications, home hazards, and footwear are other modifiable risk factors for falls in older
adults.58
One potential risk factor for falls that needs further investigation is self-reported sleep
problems.15 Sleep complaints are common in older adults. Approximately 50% of
community-dwelling older adults report poor sleep,11,12 and studies have shown that sleep
problems increase the risk of falls in older adults.15,94,97,100 Additionally, the consumption of
medications to aid sleep (e.g., sedative hypnotics) is common in older adults,21 and studies
have shown such medication use to be associated with risk of falls.21,62 A meta-analysis found
that sedatives and hypnotics (OR=1.47; 95% CI=1.35-1.62), antidepressants (OR=1.68; 95%
CI=1.47-1.91), and benzodiazepines (OR=1.57; 95% CI=1.43-1.72) have a significant
association with falls in older adults.62 In another study with community-dwelling older
adults, the use of anxiolytics/hypnotics and sedatives significantly increased the risk of falls
in men (OR=1.43; 95% CI=1.22-1.67) and in women (OR=1.33; 95% CI=1.22-1.46), when
the drug was used up to 85 days before the fall.111 However, these studies did not consider
reported sleep problems as a potential confounder when assessing the relationship.
One study has assessed the association between insomnia and hypnotic use on the risk of falls
among institutionalized population.40 This study found that older adults with insomnia but
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who did not take hypnotics, as well as those who have insomnia and who did use hypnotics,
had a greater risk of falls compared with those who did not have insomnia and did not use
hypnotics.40 Thus it remains to be seen if such an association exist among communitydwelling older adults. There is clearly a lack of literature on whether the underlying sleep
problems cause falls in older adults who take medications for sleep. Therefore, we conducted
a study to evaluate the association between sleep problems, sleep medication use, and falls in
community-dwelling adults aged 65 years or older. Identifying whether sleep problems, sleep
medication use, or both increase the risk of falls may further help healthcare decision makers
to better treat older adults with poor sleep and who are already at risk of falling.
Therefore, the objectives were: 1) to determine the prevalence of sleep problems,
sleep medication use, and falls; 2) to evaluate if sleep problems and sleep medication use was
associated with risk of falls, injurious falls, and recurrent falls in community-dwelling adults
aged 65 years or older.

4.3 Methods
4.3.1 Data Source and Study Sample
This study was a cross-sectional analysis of the 2010 Health and Retirement Study
(HRS) dataset. HRS is a longitudinal panel study that surveys more than 22,000 Americans
every two years and it is conducted by the University of Michigan.112 The HRS dataset is
available for public use with registration. The most recent wave of 2010 data was used in this
study. RAND (Research ANd Development) HRS data files were merged with 2010 physical
data files for the purpose of the analysis based on the household ID and personal ID.113
The HRS included a nationally representative sample of adults aged 50 years and
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older. The sample is selected under a multi-stage area probability sample design with
oversamples of blacks, hispanics, and residents of Florida. It has six sub-samples who were
born in different categories of years.
In this study, we included all community-dwelling adults aged 65 years or older from
the HRS dataset. We excluded those respondents who 1) resided in nursing homes during
year 2010, 2) did not responded in the year 2010 survey, or 3) had missing values on any of
the variables.

4.3.2 Outcome Variables
Falls were assessed in the HRS by asking the question, “Have you fallen down in the
last two years?” The response to this question was categorized as “yes” or “no”, and was used
to define the outcome variable in this study. If the participants responded “yes”, they were
further asked the number of times they had fallen and whether they had been injured
seriously enough to need medical treatment in any of the falls.

4.3.3 Predictor Variables
In the HRS, respondents were asked about their sleep problems through four
questions: 1) “How often do you have trouble falling asleep?” 2) “How often do you have
trouble with waking up during the night?”, 3) “How often do you have trouble with waking
up too early and not being able to fall asleep again?”, and 4) “How often do you feel really
rested when you wake up in the morning?”. The responses were categorized as “most of the
time”, “sometimes”, and “rarely or never”. For this study, participants were defined as having
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a sleep problem, if the respondents answered “most of the time” in any of the first three
questions, or “rarely or never” on the fourth question.15,95 This approach was appropriate
since the questions and responses were mostly the same with the past literature.15,95
Sleep medication use by respondents was assessed in HRS with the question: “In the
past two weeks, have you taken any medications or used other treatments to help you sleep?”
The responses were categorized as “yes” or “no”, and were used to identify respondents that
used sleep medications in this study.

4.3.4 Covariates
Based on previous studies, the covariates that are recognized as a risk factor for falls
were included in this study. Demographic variables of interest in this analysis were age,
gender, race, education level, and marital status. Other variables of interest included smoking
status, alcohol use, health status, number of comorbidities, limitation in ADL, limitation in
IADL, limitation in mobility, self-rated eye-sight, and presence of incontinence.57–59 Age was
categorized as “65-74 years old”, “75-84 years old”, and “85 years or older”. Gender was
categorized as “male” and “female”, race as “Caucasian” and “other”, and marital status as
“married” and “other”. Education level was estimated by the years of education and
categorized as “no education”, “less than high school”, “high school”, and “more than high
school”.
Smoking status was categorized as “current”, “former”, and “non-smokers”. Use of
alcohol was classified as “drinker” and “non-drinker”. Health status was self-reported and
was categorized as “excellent/very good/good”, “fair” and “poor”. Based on previous studies
using HRS data, the number of comorbidities was measured by the sum of the following self52

reported conditions: high blood pressure, diabetes, lung disease, heart disease, stroke,
emotional or psychiatric problems, arthritis, and Alzheimer’s disease.114–116 Comorbidities
were then categorized as “none”, “1-2”, “3-4” or “5 or more”.
Information about functional status was also taken into account because it is highly
related to risk of falls.58,117 The ADL included bathing, dressing, toileting, eating and
transferring. Number of limitations in ADL was the sum of any difficulties on these five tasks.
The IADL included ability to use the phone, shopping, preparing food, responsibility for own
medications, and ability to handle finances. Number of limitations in IADL was the sum of
any difficulties on these five tasks.115,118 Limitations in mobility included difficulty in any of
the following tasks: walking one block, walking several blocks, waking across a room,
climbing one flight of stairs, and climbing several flights of stairs activities. Each criteria of
functional limitation was categorized as “0”, “1-2” or “3-5”. Self-rated eye sight was
included because impaired vision has been reported to be a risk factor for falls.58,117 It was
categorized as “excellent/very good/good/fair” and “poor/legally blind”. The presence of
incontinence, categorized as “yes” or “no” was also included.57

4.3.5 Statistical Analysis
Using individual sampling weights, weighted descriptive statistics were generated
and used to summarize the characteristics of the participants. Percentages were used to
describe categorical variables, and mean and standard deviation (SD) were used to describe
continuous variables. Chi-square analysis was conducted to determine the association among
categorical variables of interest.
The effect of sleep problems, and sleep medication use, and the combined effect on
falls were assessed by multiple logistic regression models. Multi-nominal logistic regression
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models were used to assess the association between recurrent falls or injurious falls with
predictor variables with non-fallers as the reference group. The unadjusted relationship was
calculated followed by adjusted relationship with all the covariates in the model. Collinearity
was assessed among the predictor variables and covariates in the model. To assess collinearity,
correlations among the explanatory variables were assessed. Correlation coefficients larger
than 0.9 between the variables mean there is collinearity among the variables. Also, a
regression model was performed to use variance inflation factor (VIF) to check for
collinearity. A VIF greater than 10 indicates there is collinearity among the variables.
In addition, the effect of each sleep problem (‘trouble falling asleep’, ‘trouble with
waking up during the night’, ‘trouble with waking up too early and not being able to fall
asleep again’, and ‘trouble feeling rested when waking up in the morning’) on the risk of falls
was assessed. Results were reported as odds ratios (OR) and 95% confidence intervals (CI). A
p-value less than 0.05 was considered significant. All statistical analyses were performed
using SAS 9.4 statistical software (SAS Institute Inc., Cary, NC, USA).

4.4 Results
4.4.1 Population Characteristics
Based on our inclusion and exclusion criteria, we identified 10,354 older adults from
the HRS 2010 dataset. Data from 511 respondents were excluded because of missing data,
which was less than 5% of the respondents. Thus, the final dataset consisted of 9,843
participants.
Overall, 35.8% of the older adults reported a fall at least once in the last two years.
Among those reporting a fall, 29.9% had serious injuries requiring medical treatment and
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60.4% fell more than once. Refer to Figure 4.1. The proportion of older adults reporting sleep
problems and sleep medication use was 40.8% and 20.9%, respectively. Among those
reported sleep problems, 30.4% of the older adults had used sleep medications. Similarly,
among those who did not report having sleep problems, 14.4% of older adults had used sleep
medications. Sleep problems were associated with the use of sleep medications (p<0.0001)
among all participants.

Final study sample
N=9843

Non-fallers
N=6296 (64.2%)

Fallers
N=3547 (35.8%)

Non-injurious fallers
N=2478 (70.1%)

Non-recurrent fallers
N=1387 (39.6%)

Injurious fallers
N=1069 (29.9%)

Recurrent fallers
N=2160 (60.4%)

Figure 4.1 Flowchart of the Outcome Variable

Table 4.1 shows the characteristics of the participants by fallers and non-fallers. The
proportion of participants with falls was higher among those aged 85 years or older and
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among female, compared with non-fallers. Similar results were seen in participants who selfreported their health as bad, had 5 or more comorbidities, had more ADL, IADL, and
mobility limitations, and self-reported their eye sight as bad/legally blind. Additionally, the
associations between each characteristic and falls were all significant except for smoking
status.
Table 4.1 Characteristics of Community-Dwelling Older Adults by Reported Sleep Problems
and Sleep Medication Use and Falls in the U.S., 2010
Variable

Total
Age (years)†
65-74
75-84
>85
Gender*
Male
Female
Race†
Caucasian
Other
Marital Status†
Married
Other
Education
No education
< High School
High School
> High School
Smoking
Current smoker
Former smoker
Non-smoker
Alcohol†
Current drinker
Non-drinker
Self-reported
Health†
E/VG/G
Fair
Bad
Number of
comorbidities†

Total
N (%)

Fallers1
Sleep
problems2,
%

Sleep
medication
Use3 , %

Non-fallers
Sleep
problems,
%

Sleep
medication
Use, %

Yes

No

Yes

No

Yes

No

Yes

No

9843

1698

1849

888

2659

2362

3934

1140

5156

5112(55.5)
3505(32.3)
1226(12.2)

47.8
36.5
15.7

51.1
33.5
15.4

47.5
36.7
15.8

50.2
34.3
15.5

55.8
33.1
11.1

60.7
29.5
9.8

56.4
32.5
11.1

59.4
30.5
10.1

4195(43.7)
5648(56.3)

38.3
61.7

42.7
57.3

30.9
69.1

43.9
56.1

42.9
57.1

46.9
53.1

35.8
64.2

47.6
52.4

8207(89.9)
1636(10.1)

91.8
8.2

91.7
8.3

94.8
5.2

90.8
9.2

89.9
10.1

88.2
11.8

94.1
5.9

87.6
12.4

5594(54.9)
4249(45.1)

48.2
51.8

51.9
48.1

51.1
48.9

49.8
50.2

54.3
45.7

59.5
40.5

56.0
44.0

57.9
42.1

66(0.4)
2329(19.9)
3448(35.4)
4000(44.3)

0.5
24.5
32.6
42.4

0.3
18.4
38.2
43.1

0.4
21.4
34.8
43.4

0.4
21.2
35.8
42.6

0.7
21.6
35.3
42.5

0.2
17.7
35.3
46.8

0.2
16.5
34.0
49.3

0.5
19.8
35.5
44.2

846(9.4)
4769(48.4)
4228(42.2)

9.8
49.9
40.3

8.2
48.6
43.2

8.3
50.7
41.0

9.2
48.7
42.1

10.4
49.7
39.9

9.2
46.8
44.0

8.0
46.8
45.2

10.1
48.1
41.8

4698(50.8)
5145(49.2)

45.6
54.4

48.5
51.5

43.4
56.6

48.4
51.6

50.3
49.7

54.4
45.6

53.3
46.7

52.8
47.2

7076(74.5)
2022(18.6)
745(6.9)

54.7
28.6
16.7

72.9
20.7
6.4

55.8
26.8
17.4

67.1
23.7
9.2

71.4
21.3
7.3

85.2
11.9
2.8

74.9
18.1
7.0

81.3
14.8
3.9
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0
1-2
3-4
5 or more
ADL limitations†
None
1-2
3-5
IADL limitations†
None
1-2
3-5
Mobility
limitations†
None
1-2
3-5
Self-reported eye
sight†
E/VG/G /fair
Bad/legally
blind
Incontinence†
Yes
No

661(7.6)
4730(49.4)
3753(36.2)
699(6.8)

2.8
36.3
46.5
14.4

5.4
47.8
38.5
8.3

2.6
35.2
47.7
14.5

4.7
44.7
40.5
10.1

5.9
48.7
39.1
6.3

11.7
56.1
29.1
3.1

4.6
51.7
38.8
4.9

10.7
53.7
31.4
4.2

7964(82.4)
1330(12.6)
549(5.0)

64.2
24.1
11.7

77.5
16.4
6.1

63.8
23.9
12.3

73.6
18.8
7.6

84.0
11.4
4.6

91.5
6.6
1.9

87.0
8.6
4.4

89.1
8.3
2.6

8070(83.4)
1254(12.1)
519(4.5)

69.1
21.4
9.5

78.7
15.3
6.0

68.5
21.8
9.7

76.0
17.0
7.0

85.3
11.7
3.0

90.6
7.0
2.4

84.8
11.7
3.5

89.5
8.0
2.5

4137(44.3)
3485(34.6)
2221(21.1)

24.7
35.2
40.1

39.5
35.8
24.7

26.1
34.0
39.9

34.6
36.0
29.4

40.8
38.2
21.0

56.8
31.7
11.5

40.7
39.9
19.4

53.2
32.8
14.0

9161(93.8)
682(6.2)

87.6
12.4

92.8
7.2

88.1
11.9

91.1
8.9

94.2
5.8

96.6
3.4

94.6
5.4

95.9
4.1

2806(28.6)
7037(71.4)

45.3
54.7

30.0
70.0

43.1
56.9

35.3
64.7

31.2
68.8

19.4
80.6

33.4
66.6

21.6
78.4

Data source: 2010 HRS (RAND HRS data file and 2010 HRS core physical health file)
*chi-test, p-value<0.05, † <0.0001
1. Fallers=Participants who reported having a fall at least once in the previous two years.
2. Sleep problems=Participants who have trouble “most of the time” in any of sleep problems: ‘trouble falling
asleep’, ‘trouble with waking up during the night’, ‘trouble with waking up too early and not being able to fall
asleep again’. Or “rarely or never” on sleep problem: ‘trouble feeling rested when waking up in the morning’.
3. Sleep medication Use=Participants who have reported taken any medications or used other treatments to help
sleep.
ADL=activities of daily living, IADL=Instrumental Activities of Daily Living, E/VG/G=excellent/very
good/good

4.4.2 Associations between Sleep Problems, Sleep Medications, and Falls
Among individuals reporting falls, 43.3% had reported no sleep problems and no use
of sleep medications, 31.9% reported sleep problems but no use of sleep medications, 9.6%
reported no sleep problems but still used sleep medications, and 15.2% reported sleep
problems and used sleep medications.
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Table 4.2 Distribution of Predictor Variables against Falls in Community-Dwelling Older
Adults in the U.S., 2010
Variables
Sleep problems
Yes
No
Sleep medication use
Yes
No
Sleep problems + Sleep medication use
No sleep problem + No sleep med usea
No sleep problem + Sleep med useb
Sleep problem + No sleep med usec
Sleep problem + Sleep med used

Fallers
N (%)

Non-fallers
N (%)

1698 (47.2)
1849 (52.8)

2362 (37.2)
3934 (62.8)

888 (24.8)
2659 (75.2)

1140 (18.8)
5156 (81.2)

1515 (43.3)
334 (9.6)
1144 (31.9)
554 (15.2)

3443 (54.8)
491 (8.0)
1713 (26.4)
649 (10.8)

Data source: 2010 HRS dataset (RAND HRS data file and 2010 HRS core physical health file)
*Column percentages are significantly different by Rao-Scott Chi-square test p<0.05
a. No sleep problem + No sleep med use= Participants who reported no sleep problems and no use of sleep
medications
b. No sleep problem + Sleep med use= Participants who reported no sleep problems but use of sleep
medications
c. Sleep problem + No sleep med use= Participants who reported sleep problems and no use of sleep
medications
d. Sleep problem + Sleep med use= Participants who reported sleep problems and use of sleep medications

Table 4.3 reports the unadjusted and adjusted associations between sleep problems,
sleep medication use, and falls by a logistic model. In the unadjusted model, the risk of falls
was significantly higher among individuals with sleep problems, compared with those with
no sleep problems. Similarly, the risk of falls was higher among those reporting sleep
medication use, compared with those with no sleep medication use. However, the risk was
not seen in those using sleep medications after adjusting for covariates.
Compared with participants reporting no sleep problems and no sleep medication use,
those reporting sleep problems and sleep medication use had significantly increased risk of
falls (OR=1.79; 95% CI=1.54-2.08). However, after adjusting for covariates, older adults
with no sleep problems and sleep medication use had the highest increase in the risk of falls
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compared with those with sleep problems and no sleep medications use, and to those with
sleep problems and sleep medication use. All of the associations were attenuated after
adjusting the covariates in the full model but remained significant.
Table 4.3 Association between Sleep Problems, Sleep Medications Use, and Falls in
Community-Dwelling Older Adults in the U.S., 2010
Variables
Sleep problems
Yes
No
Sleep medication use
Yes
No
Sleep problems + Sleep medication use
No sleep problem + No sleep med usea
No sleep problem + Sleep med useb
Sleep problem + No sleep med usec
Sleep problem + Sleep med used

Unadjusted OR
(95% CI)

Adjusted ORe
(95%CI)

1.51‡ (1.37-1.65)
Ref

1.13* (1.01-1.25)
Ref

1.43‡ (1.26-1.62)
Ref

1.14 (1.00-1.31)
Ref

Ref
1.52‡ (1.31-1.78)
1.53‡ (1.36-1.73)
1.79‡ (1.54-2.08)

Ref
1.24† (1.05-1.47)
1.16* (1.02-1.32)
1.19* (1.01-1.41)

Data source: 2010 HRS dataset (RAND HRS data file and 2010 HRS core physical health file)
*<0.05, † <0.01, ‡ <0.0001
Ref=reference
a. No sleep problem + No sleep med use= Participants who reported no sleep problems and no use of sleep
medications
b. No sleep problem + Sleep med use= Participants who reported no sleep problems but use of sleep
medications
c. Sleep problem + No sleep med use= Participants who reported sleep problems and no use of sleep
medications
d. Sleep problem + Sleep med use= Participants who reported sleep problems and use of sleep medications
e. Full model: Adjusted for age, gender, education, marital status, race, self-reported health, alcohol, number of
comorbidities, limitations in IADL, limitations in ADL, limitations in mobility, self-rated eye sight and
incontinence

4.4.3 Associations between Sleep Problems, Sleep Medications, and Injurious Falls
The fallers were further categorized into injurious fallers and non-injurious fallers.
Among the total sample, 10.7% experienced an injurious fall while 25.1% experienced a noninjurious fall. The proportion of those with sleep problems was greater in injurious fallers
59

than non-injurious fallers and non-fallers. Similarly, the proportion of those using sleep
medications was greater in injurious fallers than non-injurious fallers and non-fallers.
Table 4.4 Distribution of Predictor Variables against Injurious Falls in Community-Dwelling
Older Adults in the U.S., 2010
Variables

Sleep problems
Yes
No
Sleep medication use
Yes
No
Sleep problems+ Sleep medication use
No sleep problem + No sleep med use1
No sleep problem + Sleep med use2
Sleep problem + No sleep med use3
Sleep problem + Sleep med use4

Non-fallers
N (%)

Non-injurious
fallers
N (%)

Injurious
fallers
N (%)

2362 (37.2) ‡
3934 (62.8)

1178 (46.4) †
1300 (53.6)

520 (49.0)
549 (51.0)

1140 (18.8) ‡
5156 (81.2)

579 (22.6) ‡
1899 (77.4)

309 (30.0) ‡
760 (70.0)

3443 (54.8) ‡
491 (8.0)
1713 (26.4)
649 (10.8)

1088 (45.3) ‡
212 (8.3)
811 (32.1)
367 (14.3)

427 (38.5) ‡
122 (12.6)
333 (31.6)
187 (17.4)

Rao-Scott Chi-square test for column percentages p-value *<0.05, † <0.01, ‡ <0.0001
a. No sleep problem + No sleep med use= Participants who reported no sleep problems and no use of sleep
medications
b. No sleep problem + Sleep med use= Participants who reported no sleep problems but use of sleep
medications
c. Sleep problem + No sleep med use= Participants who reported sleep problems and no use of sleep
medications
d. Sleep problem + Sleep med use= Participants who reported sleep problems and use of sleep medications

Multi-nominal logistic model was preformed to assess the effect of sleep problems
and sleep medication use on the risk of injurious falls. Non-fallers were considered as the
reference group. Compared with non-users, sleep medication users had a 40% higher risk of
having an injurious fall. All the groups were more likely to experience injurious falls
compared with the group with no sleep problems and no use of sleep medications. However,
the effect of sleep problems and sleep medication use did not increase the risk of noninjurious falls.
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Table 4.5 Association between Sleep Problems, Sleep Medications Use, and Injurious Falls in
Community-Dwelling Older Adults in the U.S., 2010
Variables

Sleep problems
Yes
No
Sleep medication use
Yes
No
Sleep problems + Sleep medication use
No sleep problem + No sleep med usea
No sleep problem + Sleep med useb
Sleep problem + No sleep med usec
Sleep problem + Sleep med used

Non-injurious fallers
Adjusted OR
(95% CI)

Injurious fallers
Adjusted ORe
(95% CI)

1.12 (1.00-1.25)
Ref

1.16 (0.98-1.36)
Ref

1.04 (0.89-1.22)
Ref

1.40† (1.15-1.71)
Ref

Ref
1.05 (0.86-1.30)
1.13 (0.99-1.29)
1.12 (0.92-1.35)

Ref
1.76‡ (1.40-2.20)
1.25* (1.02-1.54)
1.40* (1.08-1.82)

Data source: 2010 HRS dataset (RAND HRS data file and 2010 HRS core physical health file)
*<0.05, † <0.01, ‡ <0.0001
Ref=reference
a. No sleep problem + No sleep med use= Participants who reported no sleep problems and no use of sleep
medications
b. No sleep problem + Sleep med use= Participants who reported no sleep problems but use of sleep
medications
c. Sleep problem + No sleep med use= Participants who reported sleep problems and no use of sleep
medications
d. Sleep problem + Sleep med use= Participants who reported sleep problems and use of sleep medications
e. Full model: Adjusted for age, gender, education, marital status, race, self-reported health, alcohol, number of
comorbidities, limitations in IADL, limitations in ADL, limitations in mobility, self-rated eye sight and
incontinence

4.4.4 Associations between Sleep Problems, Sleep Medications, and Recurrent Falls
Recurrent falls were defined as falling more than once in the past two years. Among
the total sample, 14.2% were single fallers, and 21.7% were recurrent fallers. Participants
using medications or treatments for sleep were approximately 19% among non-fallers, 22%
among single fallers, and 27% in recurrent fallers. Recurrent fallers had higher proportion of
those with sleep problems compared with single fallers and non-fallers. After combining
sleep problems and sleep medication use, recurrent fallers had a higher proportion of those
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with both sleep problems and sleep medication use compared with single fallers and nonfallers.
Table 4.6 Distribution of Predictor Variables against Recurrent Falls in Community-Dwelling
Older Adults in the U.S., 2010
Variables

Sleep problems
Yes
No
Sleep medication use
Yes
No
Sleep problems + Sleep medication use
No sleep problem + No sleep med use1
No sleep problem + Sleep med use2
Sleep problem + No sleep med use3
Sleep problem + Sleep med use4

Non-fallers
N (%)

Single fallers
N (%)

Recurrent
fallers
N (%)

2362 (37.2) ‡
3934 (62.8)

569 (40.2) ‡
818 (59.8)

1129 (51.8)
1031 (48.2)

1140 (18.8) ‡
5156 (81.2)

305 (21.6) ‡
1082 (78.4)

583 (26.9) ‡
1577 (73.1)

3443 (54.8) ‡
491 (8.0)
1713 (26.4)
649 (10.8)

679 (49.7) ‡
139 (10.1)
403 (28.7)
166 (11.5)

836 (39.0) ‡
195 (9.2)
741 (34.1)
388 (17.7)

Rao-Scott Chi-square test for column percentages p-value *<0.05, † <0.01, ‡ <0.0001
a. No sleep problem + No sleep med use= Participants who reported no sleep problems and no use of sleep
medications
b. No sleep problem + Sleep med use= Participants who reported no sleep problems but use of sleep
medications
c. Sleep problem + No sleep med use= Participants who reported sleep problems and no use of sleep
medications
d. Sleep problem + Sleep med use= Participants who reported sleep problems and use of sleep medications

Multi-nominal logistic model was performed to assess the effect of sleep problems
and sleep medication use on the risk of recurrent falls. Non-fallers were considered as the
reference group. Compared with participants with no sleep problems, those with sleep
problems were 26% more likely to have a recurrent fall. Similarly, compared with non-users
of sleep medications, users had 21% higher odds of having a recurrent fall. However, sleep
problems and sleep medication use did not affect the risk of non-recurrent falls. In addition,
the group with sleep problems and sleep medication use had a significantly higher risk of
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recurrent falls compared with the group with no sleep problems and no sleep medication use.
Table 4.7 Association between Sleep Problems, Sleep Medications Use, and Recurrent Falls
in Community-Dwelling Older Adults in the U.S., 2010
Variables

Sleep problems
Yes
No
Sleep medication use
Yes
No
Sleep problems + Sleep medication use
No sleep problem + No sleep med usea
No sleep problem + Sleep med useb
Sleep problem + No sleep med usec
Sleep problem + Sleep med used

Single falls
Adjusted OR
(95% CI)

Recurrent falls
Adjusted ORe
(95%CI)

0.97 (0.83-1.12)
Ref

1.26† (1.12-1.42)
Ref

1.05 (0.89-1.23)
Ref

1.21* (1.04-1.42)
Ref

Ref
1.24 (0.99-1.55)
1.03 (0.86-1.23)
0.93 (0.75-1.16)

Ref
1.25 (1.00-1.58)
1.27† (1.10-1.47)
1.40† (1.17-1.68)

Data source: 2010 HRS dataset (RAND HRS data file and 2010 HRS core physical health file)
*<0.05, † <0.01, ‡ <0.0001
Ref=reference
a. No sleep problem + No sleep med use= Participants who reported no sleep problems and no use of sleep
medications
b. No sleep problem + Sleep med use= Participants who reported no sleep problems but use of sleep
medications
c. Sleep problem + No sleep med use= Participants who reported sleep problems and no use of sleep
medications
d. Sleep problem + Sleep med use= Participants who reported sleep problems and use of sleep medications
e. Full model: Adjusted for age, gender, education, marital status, race, self-reported health, alcohol, number of
comorbidities, limitations in IADL, limitations in ADL, limitations in mobility, self-rated eye sight and
incontinence

4.4.5 Association between Type of Reported Sleep Problems and Falls
Among those individuals reporting a fall, 16.9% reported having trouble falling
asleep, 31.1% reported trouble waking up during the night, 15.6% reported trouble with
waking up too early and not being able to fall asleep again, and 14.8% reported trouble
feeling rested when waking up in the morning.
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Table 4.8 reports the relationship between type of sleep problem and the risk for falls.
The risk of falls was higher among respondents reporting any of the four sleep problems in
the unadjusted associations. However, after adjusting for covariates including the sleep
medications use, only respondents with “trouble falling asleep” had an increased risk of falls.
Table 4.8 Association between Type of Sleep Problems and Falls in Community-Dwelling
Older Adults in the U.S., 2010
Variables
Trouble falling asleep
Yes
No
Trouble with waking up during the night
Yes
No
Trouble with waking up too early and not
being able to fall asleep again
Yes
No
Trouble feeling rested when waking up in
the morning
Yes
No

Unadjusted OR
(95% CI)

Adjusted ORa
(95% CI)

1.75‡ (1.54-1.98)
Ref

1.22† (1.07-1.40)
Ref

1.35‡ (1.22-1.50)
Ref

1.07 (0.96-1.20)
Ref

1.50‡ (1.31-1.71)
Ref

1.12 (0.98-1.30)
Ref

1.54‡ (1.34-1.78)
Ref

0.98 (0.84-1.14)
Ref

Data source: 2010 HRS dataset (RAND HRS data file and 2010 HRS core physical health file)
*<0.05, † <0.01, ‡ <0.0001
Ref=reference
a. Full model: Adjusted for age, gender, education, marital status, race, self-reported health, alcohol, number of
comorbidities, limitations in IADL, limitations in ADL, limitations in mobility, self-rated eye sight, incontinence
and sleep medication use

4.5 Discussion
The purposes of this study were to determine the prevalence of sleep problems, sleep
medication use, and falls, and to assess the effect of sleep problems, sleep medication use,
and the combined effect on the risk of falls, injurious falls, and recurrent falls in communitydwelling older adults.
In a representative sample of community-dwelling older adults in 2010, this study
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showed that 35.8% of the participants had a fall at least once in the last two years. Similar
percentage of older adults had fallen compared with previous studies reporting that one in
three community-dwelling older adults have a fall per year.119 However, there was no
standardized definition of fall in the HRS survey. The question regarding falls in the HRS
survey only asked whether the participants have fallen down in the last two years, but what
constitutes a fall was not defined further. About 5 to 10% of falls in community-dwelling
older adults results in severe head injury and joint dislocation, and an additional 5% in a
fracture.120 Approximately 30% of falls led to serious injuries in this study, thus, it is possible
that respondents were more likely to remember to report falls that required medical
treatments. Additionally, this study found that 40.8% had sleep problems in the last two years.
The prevalence was similar to previous studies.11,12 Only 20.9% used medications or other
treatments to help sleep in the past two weeks, and among those who had sleep problems,
only 30.4% used sleep medications. This could mainly be because the use of sleep
medications was assessed in the past two weeks in the survey which was a short time frame
relative to the time over which sleep problems were reported.
Older adults with reported sleep problems had a significant increase in the risk of
falls after adjusting for covariates (OR=1.13; 95% CI=1.01-1.25). The possible mechanisms
could be that poor sleep may cause daytime sleepiness, cognitive dysfunction, and slower
response time that could result in falls.42,44,45,117 Although the risk attenuated after considering
covariates, the risk was still observed. However, older adults who used sleep medications or
other treatment for sleep did not find risk of falls after adjusting for covariates. A study by
Ensrud and colleagues that followed community-dwelling older women on hypnotics for 1
year for incidence of falls found that women taking benzodiazepines (multivariate odds ratio,
MOR=1.34; 95% CI=1.09-1.63), antidepressants (MOR=1.54; 95% CI=1.14-2.07), or
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antiepileptics (MOR=2.56; 95% CI=1.49-4.41) were likely to experience falls at least once.69
Sedative hypnotics could increase falls by the effect on postural instability, psychomotor
impairment and cognitive dysfunction.67 Furthermore, the risk of falls associated with these
medications could be increased because of age-related changes in physiology resulting in
altered pharmacokinetics and pharmacodynamics in older adults.67 Therefore, the lack of
significance in the finding could again be because of a short time frame on question asking
about sleep medication use.
In addition, there was increased risk of falls among older adults who had sleep
problems and who used sleep medications. However, after adjusting for covariates, older
adults with no sleep problems and who used sleep medications had the highest risk of falls
compared with other groups. This finding suggests that sleep medications did not have a
protective effect on falls when considering sleep problems in the association. A study by
Avidan and colleagues assessed the risk of falls in the same four groups with a crosstabulation of insomnia and use of sedative hypnotics: 1) insomnia, hypnotic use, 2) insomnia,
no hypnotic use, 3) no insomnia, hypnotic use, and 4) no insomnia, no hypnotic use.40
However, the results are inconsistent with the current study. Avidan and colleagues found that
insomniacs who did not take hypnotics (OR=1.55; 95% CI =1.41-1.71) and insomniacs who
took hypnotics had a significant increase in the risk of falls (OR=1.32; 95% CI=1.02-1.70).40
Insomnia without hypnotics had the highest risk of falls compared with any other groups and
hypnotic use had a protective effect on falls in older adults, suggesting that the condition of
insomnia might have been better treated with the medication resulting in fewer falls.40
Although the study by Avidan and colleagues and the current study have conflicting results,
the presence of sleep problems, such as insomnia, was found as a key risk factor for falls.
The risk of injurious falls associated with sleep problems and sleep medication use
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was also assessed. Sleep medication use but not sleep problems was significantly associated
with a risk of injurious falls. A prospective cohort study also found a significant increased
risk of injurious falls related to the use of sedative or hypnotics (RR=1.50; 95% CI=1.032.19),88 but other studies did not find sleep problems to be related to falls that required
medical attention for an injury.96,103 The effect of sleep problems and sleep medication use on
the risk of injurious falls showed that the group with no sleep problems and sleep medication
use had the highest risk of injurious falls than those with sleep problems and no sleep
medications use, and to those with sleep problems and sleep medication use compared to the
reference group. This pattern was similar to the risk of falls generally.
Moreover, the risk of recurrent falls was studied. Older adults with sleep problems
and those with sleep medication use were more likely to have a recurrent fall. Other studies
also showed the association between sleep problems and recurrent falls,104 and use of CNS
medications and recurrent falls.121 The risk of recurrent falls was seen in older adults with
sleep problems and no sleep medication use and in those with sleep problems and sleep
medication use. The effect of sleep problems and sleep medication use was not significant for
risk of a single fall.
In this study, the risk of falls by type of reported sleep problem among older adults
was also assessed. Each sleep problem had a significant increase in the unadjusted risk of
falls, however, only ‘trouble falling asleep’ significantly increased the risk of falls after
adjusting for covariates including the use of sleep medications. A study by Brassington and
colleagues evaluated the same aspects of sleep disturbance in older adults as in the current
study except for one type of sleep problem, which was ‘trouble feeling rested when waking
up in the morning’.15 The authors found that difficulty falling asleep at night (OR=1.53; 95%
CI=1.04-2.24), waking up during the night (OR=1.91; 95% CI=1.44-2.54), and waking up too
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early in the morning and not being able to fall asleep again (OR=1.64; 95% CI=1.11-2.42)
were significantly associated with the occurrence of falls after adjusting for covariates
including a use of prescription medication.15 The number of covariates that were adjusted for
was fewer than in the current study, and therefore may not have adjusted for the effect of
confounders such as limitations in ADL, instrumental IADL, mobility, and incontinence. In
contrast, Teo and colleagues evaluated the same categories of nighttime sleep problems and
used the same scale as Brassington and colleagues and reported conflicting findings.95 Teo
and collegues did not find a significant increase in the risk of falls in the same nighttime sleep
problems after adjusting for the covariates age, CNS drug use, cardiovascular system drug
use, and the presence of nocturia.95 While results from our study add to the findings from
previous studies, further prospective research in community-dwelling older adults is needed
to accurately quantify the risk of falls by type of sleep problem.
Some strengths of this study may be noted. Since the HRS study had a representative
sample of older adults, national estimates were obtained. Also, several risk factors, such as
limitations in ADL and IADL, were controlled as covariates in this study. However, as with
any study, this study has limitations. First, since information was self-reported, there could be
misclassification bias or recall bias. Second, because this is a cross-sectional study based on
self-reported information, causal relationships could not be explored. Third, falls were not
clearly defined in the HRS survey. The study would have been strengthened if the survey had
included a standard definition of falls. Variations in the definition of falls could result in
misclassification bias. Fourth, respondents were asked if they had experienced a fall and
sleep problems in the last two years. This may have resulted in recall bias, thus limiting the
generalizability of our findings. Additionally, unlike other survey questions where
respondents were asked to provide information based on their experience during the last two
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years, the survey question on assessing sleep medication use only asked respondents to
provide information based on their experience during the past two weeks. The differences in
the time interval may result in lack of temporal relationship between drug exposure and the
outcome. Still, the study results add valuable information to the current literature by shedding
light on sleep problem, sleep medication use, and falls in community-dwelling older adults.
Finally, information on the circumstances of falls were not collected in HRS and were
therefore not included in this study. This information would have been useful and should be
collected in future studies.

4.6 Conclusion
In conclusion, this study found that sleep problems, use of sleep medications, and
falls are common among community-dwelling older adults. This study adds to the literature
by assessing the combined effect of sleep problems and sleep medication use on risk of falls,
injurious falls, and recurrent falls in community-dwelling older adults. Older adults without
sleep problems and taking sleep medication had the highest risk of falls compared to those
with sleep problems and taking sleep medications, those with sleep problems and not taking
sleep medications, and those without sleep problems and not taking sleep medications. Health
care professionals should consider medication-associated risk when treating sleep problems
in community-dwelling older adults. More studies are needed to examine this association in
community-dwelling older adults.
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Chapter 5
The Effect of Sleep Medication Use and Poor Sleep Quality on Risk of Falls in
Community-Dwelling Older Adults

This chapter described a community engage research study where primary data was
collected to investigate the effect of poor sleep quality and sleep medication use on risk of
falls in community-dwelling older adults is described.

5.1 Abstract
Introduction: Sleep complaints and the consumption of medications to aid sleep are
common in older adults. However, very few studies have assessed the combined impact of
poor sleep and sleep medication use on the risk of falls.
Objective: The main objective was to evaluate the association between sleep medication use,
sleep quality, and falls in independently-living adults 65 years or older. Sleep quality, use of
sleep medications, and the outcome “falls” in the population were also described.
Methods: This was a 6-month prospective cohort study of older adults residing in
independent living senior housing. Sleep quality was assessed with the Pittsburgh Sleep
Quality Index (PSQI) and a medication review was conducted. Falls were collected over 6
months by diary. Logistic regression modeling was used to examine the effect of sleep
problems, sleep medications, and both on the risk of falls after controlling for covariates.
Statistical analysis was performed using SAS 9.4 statistical software.
Results: Among 113 community-dwelling older adults (female=76.1%, mean age ±SD= 81.1
70

±8.6), 46.9% fell at least once during 6 months. Of the total participants, 62.8% of those had
poor sleep quality based on the mean PSQI score of more than five. Among sleep medication
users, 22% used multiple sleep aids, and 40% used potentially inappropriate Over-theCounter (OTC) products and alcohol for sleep. Sleep medication use (OR=2.65; 95%
CI=1.04-6.72), but not poor sleep quality, predicted prospective falls after adjusting for
covariates. Compared with participants reporting good sleep quality and no sleep medication
use, those who report poor sleep quality and sleep medication use had an increased risk of
falls after adjusting for covariates (OR=3.23; 95% CI=1.05-9.91). The risk for falls was not
significant in group with good sleep quality and sleep medication use and the group with poor
sleep quality and no sleep medication.
Conclusion: This study was the first to evaluate the associations between poor sleep quality,
use of sleep medications, and falls in community-dwelling older adults. A combined effect of
sleep quality and sleep medication use on the risk of falls suggests that medication
effectiveness may be an important factor to consider in understanding the risk of falls
associated with sedative medications.
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5.2 Introduction
Falls are among the most common and serious problems faced by older adults. One
third of adults who are 65 years of age or more fall at least once in the community, and the
percentage increases up to 50% among those aged 80 years old or more.45 Risk factors for
falls can be classified as modifiable and non-modifiable factors. Modifiable risk factors
include impaired vision, impaired balance and mobility, orthostatic hypotension, fear of
falling, mood disorder, osteoporosis, incontinence, and polypharmacy while non-modifiable
risk factors include age, gender, and race.57,58
Several studies have documented the risk of falls associated with sedative hypnotics.
A meta-analysis which evaluated the impact of nine medication classes on falls in older adults
found that sedatives and hypnotics (OR=1.47; 95% CI=1.35-1.62), antidepressants (OR=1.68;
95% CI=1.47-1.91), and benzodiazepines (OR=1.57; 95% CI=1.43-1.72) have a significant
association with falls.62 Another meta-analysis which provided an update of the literature in
2011 found the psychotropic drugs such as antidepressants (OR=1.44; 95% CI=1.31-1.59),
benzodiazepines (OR=1.31; 95% CI=1.16-1.47), and hypnotics (OR=1.40; 95% CI=1.241.58) were significantly related to any falls in adults who are aged more than 60 years.63 This
suggests that medications that are frequently used to aid sleep have an association with falls
in older adults. Sedative hypnotics may cause daytime sedation and dizziness, and cause
problems associated with reaction time and coordination that can increase the risk of falls in
this population.64–67 Most studies that have assessed the relationship between sedative
hypnotics did not investigate whether sleep problems could be the underlying risk factor for
falls.
Sleep complaints are common in older adults.11,12 Approximately 50% of
independently living older adults aged 65 years or older in U.S. reporting a sleep complaint.11
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Older adults are often dissatisfied with the quality of their sleep.13 Poor sleep quality is
related to decreased psychomotor performance18 and cognitive function that may increase the
risk of falls.40 Few studies have shown an increased risk of falls in older adults with poor
sleep (e.g., nighttime sleep problems, daytime sleepiness and short or long sleep
duration).15,94,95,101,102
A study that evaluated the relationship between insomnia, hypnotic use, and falls among
institutionalized older adults found that older adults with insomnia with no hypnotic use and
those with insomnia with hypnotic use had increased risks of falls compared with those
without insomnia and without hypnotic use. However, it remains unclear whether the drug or
the indication for the drug use, which is poor sleep, contribute more to the risk of falls in
community-dwelling older adults. There is a need to assess confounding by indication
between poor sleep quality, sleep medication use, and falls. Therefore, the objective of this
study was to determine if sleep medication use and poor sleep quality is associated with risk
of falls in community-dwelling adults aged 65 years or older.

5.3 Methods
5.3.1 Study Setting
This study was conducted in three senior housing settings located in Richmond,
Virginia. Residents of the largest of these three communities completed a survey conducted
by a retirement community indicating that falls, sleep problems and overmedication were all
among their top ten health concerns (data not published). This study was responsive to their
interest in addressing these issues through research. The study protocol, consent forms and
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recruitment materials for the study were approved by the Virginia Commonwealth University
Institutional Review Board (IRB) in March 2013. (Appendices B, C, and D)

5.3.2 Study Design and Study Participants
This was a multi-center, prospective cohort study with a follow-up of 6 months to
observe the incidence of falls. The study enrolled independently living adults aged 65 years
or older. The first volunteer was enrolled in June 2013 and the recruitment was conducted
through February 2014. The study was completed in August 2014.
Individuals were included if they met the following criteria:
(1) Persons who were aged 65 years or above.
(2) Persons who were able to read and converse in English.
(3) Persons who were expected to reside at the retirement community for at least 6 months
after the study initiation. Volunteers were asked if they had any plans to move out of the
retirement community within 6 months.
Individuals were excluded if they met the following criteria:
(1) Persons unable to provide written informed consent. Participation in the study was
voluntary. There was no penalty or loss of benefits for not participating.
(2) Persons who were found to be taking any medications for cognitive impairments (i.e.,
donepezil, rivastigmine, galantamine, or memantine) in the medication review. Those who
had problems with cognitive function may have problems remembering their falls during the
study follow-up period.
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(3) Persons who scored 23 or below on the Mini Mental State Examination (MMSE) were
excluded. Questions on the MMSE were asked by the researcher. MMSE is commonly used
to evaluate cognitive status in older adults. It tests components of orientation, registration,
attention and calculation, recall, language, and visuospatial construction. The total score
ranges from 0 to 30 and a score of 23 or below may indicate the presence of cognitive
impairment. It takes about 15 minutes to complete.64 Those who had problems in cognitive
function may have problems remembering their falls during the study follow-up period.
(4) Persons who were not willing to keep the monthly log. The fall diaries were used to
document falls. Those who did not wish to keep the fall diaries could not be followed during
the study period.
(5) Persons who were nonambulatory. Those who were bed bound or used wheelchairs
exclusively for ambulation were excluded because their risk of falls may be very different
from those who are ambulatory.

5.3.3 Study Recruitment
Several methods were used to recruit participants in this study.
(1) The researcher attended short meetings in the senior housing communities to briefly
introduce the study. Short meetings were either at a town hall meeting or morning coffee
breaks.
(2) A brief description of the study was introduced in the weekly newsletter in the
communities.
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(3) Advertising flyers approved by the Virginia Commonwealth University IRB were posted
in the pharmacy or common area in the communities.
(4) A poster session about sleep problems in older adults that could be beneficial to the
residents was held in the senior housing communities. Advertisement flyers and study
brochures were placed near the poster so that the residents had a chance to be introduced to
the study. Also, those who were interested in the study were screened for study eligibility
according to the inclusion and exclusion criteria.
(5) The IRB approved consent form was given to eligible participants who volunteered. They
had time to review the consent form with their family or primary care physician before
making a final decision.
(6) After the informed consent, name and contact information were collected from the
participants. Telephone contacts with these volunteers were conducted by the researcher to
arrange a meeting at a private area within the community or at the participant’s residence
based on his/her preference.
(7) Compensation was provided with a gift card or cash of $10 at the beginning of the study
and $25 at the end of the study.
The recruitment period was from June 2014 to February 2014 and advertising continued
throughout this period.

5.3.4 Data Collection
Baseline assessment:
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Baseline demographic information was collected including age, gender, race,
education level and smoking status (Appendix E: Baseline Demographics).
There were two predictor variables: the quality of sleep and the use of medications
for sleep. Upon enrollment, the PSQI was administered to measure the quality of sleep. Poor
sleep quality was defined as a total score of more than five on the PSQI.14 Volunteers were
identified as having either poor quality of sleep or not.
The PSQI is a validated measure of subjective sleep quality and sleep disturbances
over a 1-month period.14 It has 19 items and is divided into sections that measure subjective
sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, use of
sleeping medication, and daytime dysfunction. The scores range from 0 to 21 (0= best sleep
quality and 21= poorest sleep quality). A score of more than five was used to identify those
with poor sleep quality. The researcher guided participants through the survey.
Approximately 15 minutes was needed to complete the survey. This instrument was selected
because of its’ robust psychometric properties related to general sleep quality and
applicability.122
The other predictor variable was the use of medications for sleep. A medication
review was conducted to identify the use of medications for sleep. Medications that were
prescribed for, or used by, patients to aid sleep, including alcohol (Appendix F: Medication
Review, Appendix G: Questions about Alcohol Intake for Sleep) were identified during the
medication review at the baseline assessment. Participants were asked to bring all their
medications, including prescription medications, nonprescription medications, herbal aids
and dietary supplements that they have used within the past month at the time of the
interview. If they did not bring their medications, medical prescriptions or drug packages
were accepted. All drugs were recorded with generic names. For complete data collection, the
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dose, and the frequency of medication use were recorded. Participants were categorized as
sleep medication users if they verbally disclosed that using any agents for sleep during the
previous month at the baseline assessment, and as non-users if they verbally stated that they
did not use any agents for sleep in the previous month at the baseline assessment.
Several covariates were measured at the baseline assessment. Falls Risk for Older
People in the Community scale (FROP-Com) was used to measure the baseline risk of
falls.123 The FROP-Com was selected for this study because it is a comprehensive falls
assessment that asks about multiple factors related to risk of falls in community-dwelling
older adults. It is a multidimensional assessment that asks questions about a history of falls in
the past 12 months, number of medications, and cognitive, marital and functional status. This
questionnaire also assesses the number of medical conditions, number of prescription
medications, and number of specific types of medications (i.e., sedatives, antidepressants,
anti-epileptics, central acting analgesics, digoxin, diuretics, type 1a antiarrythmics, and
vestibular suppressants). The answers on questions about medications in FROP-Com were
obtained from the medication reviews and the answers about medical conditions were
obtained from the Functional Comorbidity Index (FCI) answers. Moreover, the FROP-Com
assesses sensory loss including feet and footwear problems, continence, nutrition,
environment, balance, and gait/physical activity. It is a 28-item clinician-rated scale of 13 risk
factors for falling. Each item is scored either dichotomously or on a 0 to 3 scale. The overall
score is from 0 to 60, with a score of 0 to 11 indicating mild fall risk, 12 to 18 indicating a
moderate fall risk, and 19 to 60 indicating a high fall risk. It is a reliable tool and has been
validated in older adults. It requires no equipment or specialist knowledge and it will take
about 15 to 20 minutes to complete.
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The Functional Comorbidity Index (FCI) was used to measure comorbidities,124
however, it was only used in the analysis to provide the answers for FROP-Com about
medical conditions. It was developed specifically for use in the general population with
physical function as the outcome of interest. The FCI can be used to adjust for the effect of
comorbidity on physical function in the same manner that other comorbidity indices are used
to adjust for the effect of comorbidity on mortality. It contains diseases (e.g., visual
impairment, osteoporosis, arthritis etc.) for a total of 18 diagnoses scored by adding the
number of “yes” answers. A score of 0 indicates no comorbid illness and a score of 18
indicates the highest number of comorbid illnesses. About 5 minutes was needed for
completion (Appendix H: Functional Comorbidity Index).
Table 5.1 Predictor Variables and Covariates Measured during the Baseline Assessment
Variables

Measurement

Predictor variables
Sleep quality
Sleep medication use

PSQI
Medication Reviews (Appendix F)

Covariates
Age58,125
Gender58,126
Race58,127
Education level58,128
Smoking status101–103
Marital status
Baseline risk of falls

Baseline Demographics (Appendix E)

FROP-Com

Questionnaires were administered on one occasion (one point in time). The estimated
time to complete the baseline assessment was one hour. The researcher or a research assistant
administered the surveys to the participants. The baseline assessment was conducted with
each participant either in a private area within the housing community or in their apartment,
according to the participant’s preference.
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Follow-up assessment:
The outcome of interest was the incidence of falls. The definition of falls provided by
the WHO which is “an event which results in a person coming to rest inadvertently on the
ground floor or other lower level”54 was used. All occurrences of falls were collected over a
6-month period. The researcher demonstrated to the participants what a fall is to capture falls
according to the definition provided by the WHO. This was necessary because individuals
may have different ideas about what qualifies as a fall.
During the follow-up period of 6 months, the investigator contacted participants on a
monthly basis either by meeting with them in person or calling them on the phone.
Participants were asked if they had experienced any falls in the past month and if they had
made any change in the usage of medications for sleep (e.g., whether they started taking any
new medications for sleep, stopped taking medications for sleep, or switched to different
medications for sleep) (Appendix I: Monthly Follow-up Questions). This information was
used to assess whether there was change from baseline assessment of sleep medication use.
Several questions from the PSQI about sleep duration and subjective sleep quality were asked
to calculate sleep efficiency and determine whether there was a change in sleep efficiency
over the 6 month follow up period.
In addition, participants were given fall diaries (Appendix J: The Fall Diary).
Participants were asked to put a check mark at the end of each week, if they experienced no
falls during the previous seven days. They were also asked to call the researcher within 48
hours, if a fall has occurred. Questions (Appendix K: Fall Questionnaire) were asked by the
researcher to ascertain that a fall had occurred (according to the fall definition) when the
participants called to report a fall. The first four questions in the “Fall Questionnaire” helped
identify and ascertain falls in older adults, the fifth question was used to obtain descriptive
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information on the outcome, and the last question was used to observe whether participants
had changed any of the medications after the recent fall. During the monthly meetings, fall
diaries were reviewed by the researcher. The researcher encouraged those who are not
completing their diaries and re-educated them about falls to reinforce the definition of falls at
the monthly meetings.

Recruitment
-Advertising
-Screening

Baseline Assessment
-Medications
-Sleep Quality
-Demographics
-Fall Risk

Follow-up Assessment
Data Analysis
- Six monthly
follow-up meetings
-Intent-to-treat
or telephone calls
analysis
-Occurrence of Falls
-Change of sleep
medication and
sleep efficiency

Figure 5.1 Summary of Data Collection Process

5.3.5 Statistical Analysis
Sample size estimation:
Sample size was estimated to be at least 35 participants in each group which was a
total of 140 participants. Alpha level was equal to 0.05 with 80% power and an effect size of
0.079.129 For sample calculation, nQuery Advisor® version 7.0 was used.
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Analysis Plan:
Descriptive statistics were reported. Percentages were used to describe categorical data
and mean and SD were used to describe quantitative data. Chi-square tests or Fisher’s exact
test was conducted to determine the association among categorical variables of interest.
Student’s t-test was conducted to determine differences between continuous variables of
interest.
Multiple logistic regression was used to examine the effect of poor sleep quality, sleep
medication use, and both after controlling for covariates. The combined effect of poor sleep
quality and sleep medication use was assessed by having four categorical variables
representing four groups: 1) poor sleep quality and no sleep medication use, 2) good sleep
quality and sleep medication use, 3) poor sleep quality and sleep medication use, and 4) good
sleep quality and no sleep medication use (the reference group). It was an intent-to-treat
analysis. Confounders were identified based on the bivariate association between exposure
variables and the outcome variable. However, if a confounder was non-significant, it was still
added in the model because of the evidence of a risk factor for falls in the literature.
Collinearity was assessed among the predictor variables and covariates in the model. To
assess collinearity, correlations among the explanatory variables were assessed. Correlation
coefficients larger than 0.9 between the variables meant there was collinearity among the
variables. Also, a regression model was performed to use variance inflation factor (VIF) to
check for collinearity. A VIF greater than 10 mean there is collinearity among the variables.
The proportion of those who continuously used sleep medications, those who did not use
sleep medications for 6 months, and those who started using sleep medications during the
follow-up period were reported. The proportion of those who experienced a change in sleep
efficiency after 6 months was reported. SAS 9.4 statistical software was used to carry out all
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statistical analyses at α=0.05 (SAS Institute Inc., Cary, NC, USA).

5.4 Results
5.4.1 Descriptive Results
A total of 116 participants were recruited between June 2013 and February 2014.
During the recruitment process, 19 potential volunteers were excluded during screening
primarily because of low MMSE scores. Three participants were lost to follow-up, thus 113
of total participants were available for data analysis. Figure 6.1 is the participants flow chart
based on the STROBE (Strengthening the Reporting of Observational Studies in
Epidemiology) statement.130
The baseline demographic characteristics and covariates are shown in Table 5.2. The
study sample had a mean age of 81.08 years (SD=8.57) and approximately 40% of the
participants were 85 years or older. The average score on the MMSE was 27.70 (SD=1.70).
Among 113 participants, 46.9% (n=53) fell at least once during 6 months,
specifically 23.0% fell once and 23.9% fell more than once. The mean PSQI global score was
6.96 ±3.68. Among participants 62.8% had poor sleep quality (n=71) and 37.2% had good
sleep quality (n=42). Of the total participants, 44.2% (n=50) used medications or treatments
to aid sleep. Among sleep medication users, 22% used more than one medication or other
treatments for sleep.
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Recruitment
A*: 94 volunteers
B: 31 volunteers
C: 20 volunteers
n=145

NOT ASSESSED FOR ELIGIBILITY
(Total=10):



Assessed for eligibility
A: 92 volunteers
B: 30 volunteers
C: 13 volunteers
n=135

Cancelled the meeting
Not eligible for the 2nd stage of
recruitment

n=5
n=5

EXCLUDED (Total= 19):

1.




2.


INELIGIBLE
Age <65 years
n=3
Took medications for memory
n=3
MMSE<24
n=7
Wheelchair bound
n=1
ELIGIBLE BUT NOT RECRUITED
Refused to continue the baseline
interview
n=5

Total recruited
n=116

LOST TO FOLLOW-UP (Total=3):





Discontinued
Passed away
Moved out of the residence

DATA AVAILABLE
FOR ANALYSIS:
Total n=113

Figure 6.1 Participants Flow Chart131
*A, B, and C represent different independent living senior housings.
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n=1
n=1
n=1

Table 5.2 Characteristics of Community-Dwelling Older Adults Stratified by Falls, Sleep
Quality, and Sleep Medication Use
Variable

Total
Age (years)
65-74
75-84
>85
Gender
Male
Female
Race
Caucasian
Other
Marital Status
Married
Other
Education
< High School
High School
> High School
Smoking
Current smoker
Former smoker
Non-smoker
FROP-Com*
Mild falls risk
Moderate falls risk
High falls risk

Fallersa
Sleep
qualityb
(%)

Sleep
medication
Usec (%)

Non-fallers
Sleep
quality
(%)

Sleep
medication
Use (%)

Poor

Good

Yes

No

Poor

Good

Yes

No

113

39

14

29

24

36

24

21

39

30 (26.6)
37 (32.7)
46 (40.7)

38.5
33.3
28.2

7.2
21.4
71.4

48.3
34.5
17.2

8.3
25.0
66.7

28.1
40.6
31.3

17.9
28.6
53.6

28.6
47.6
23.8

20.5
28.2
51.3

27 (23.9)
86 (76.1)

30.8
69.2

28.6
71.4

34.5
65.5

25.0
75.0

21.9
78.1

85.7
14.3

28.6
71.4

12.8
87.2

89 (78.8)
24 (21.2)

71.8
28.2

78.6
21.4

69.0
31.0

79.2
20.8

71.9
28.1

95.8
4.2

81.0
19.0

84.6
15.4

17(15.0)
96 (85.0)

12.8
87.2

14.3
85.7

13.8
86.2

12.5
87.5

12.5
87.5

21.4
78.6

28.6
71.4

10.3
89.7

11 (9.7)
41 (36.3)
61 (54.0)

12.8
38.5
48.7

0
42.9
57.1

6.9
37.9
55.2

12.5
41.7
45.8

12.5
40.6
46.9

7.1
25.0
67.9

9.5
23.8
66.7

10.2
38.5
51.3

10 (8.9)
48 (42.5)
55 (48.7)

12.8
46.2
41.0

14.3
35.7
50.0

17.3
37.9
44.8

8.3
50.0
41.7

9.4
40.6
50.0

0
57.1
42.9

4.7
57.1
38.1

5.1
33.3
61.5

71 (62.8)
36 (31.9)
6 (5.3)

43.6
43.6
12.8

57.1
35.7
7.2

44.8
44.8
10.3

50.0
37.5
12.5

71.9
28.1
0

82.1
17.9
0

81.0
19.0
0

74.4
25.6
0

Total
N (%)

*Chi-test, p-value<0.05
a. Fallers= Participants who fell down at least once in the past 6 months
b. Poor sleep quality= PSQI>5
c. Sleep medication Use= Participants who have taken any medications or used other treatments to help sleep in
the past month
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5.4.2 Sleep Quality Outcomes
There was a statistically significant relationship between quality of sleep and falls
(p=0.0262). There was a statistically significant difference in the mean PSQI scores between
fallers and non-fallers (t=-3.37, p=0.0011). Fallers had a significantly higher mean score on
the PSQI than non-fallers.
The mean and standard deviation of each component of the PSQI is shown in Table
5.3. A higher mean score indicates more difficulty in a given component while a lower mean
score indicates less difficulty except for the score on the use of sleeping medication
component. Here the higher score indicates higher frequency use of sleep medications in a
week compared with a lower score that indicates lower frequency use in a week or no use at
all in the past month. Fallers had a higher mean score on the use of sleeping medications and
a lower score on daytime dysfunction. Non-fallers had a higher score on sleep disturbance
and a lower score on daytime dysfunction. Significant differences in sleep latency, sleep
disturbances, use of sleeping medications, and daytime dysfunction between fallers and nonfallers were observed.

Table 5.3 Mean (±SD) on Each Component of the PSQI for Fallers and Non-fallers
Variables
PSQI
Subjective sleep quality
Sleep latency
Sleep duration
Sleep efficiency
Sleep disturbances
Use of sleeping medication
Daytime dysfunction
Total

Total
mean (SD)
6.96 (3.68)
0.80 (0.63)
1.23 (1.05)
0.64 (0.98)
1.09 (1.15)
1.21 (0.51)
1.23 (1.43)
0.77 (0.69)
113

Fallersa
mean (SD)
8.17 (3.70)
0.87 (0.68)
1.45 (1.12)
0.68 (1.07)
1.28 (1.23)
1.32 (0.61)
1.60 (1.49)
0.96 (0.73)
53

Non-fallers
mean (SD)
5.90 (3.07)
0.73 (0.58)
1.03 (0.96)
0.60 (0.91)
0.92 (1.05)
1.12 (0.37)
0.90 (1.32)
0.60 (0.62)
60

a. Fallers= Participants who have fallen down at least once in the past 6 months
b. p-value from t-test between fallers and non-fallers and each component of PSQI
*p-value<0.05
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p-valueb
0.0009*
0.2582
0.0338*
0.6707
0.0900
0.0324*
0.0086*
0.0052*

Table 5.4 shows the percentage for fallers and non-fallers on the components of the
PSQI. Sleep disturbance and daytime dysfunction components were not included. Fallers had
higher percentages of participants with poor sleep quality than non-fallers.

Table 5.4 Percentages on Each Component of the PSQI by for Fallers and Non-fallers
Components
PSQI >5a
Subjective sleep quality
Very good
Fairly good
Fairly bad
Very bad
Sleep latency
(Minutes to fall asleep)
≤15 minutes
16-30 minutes
31-60 minutes
>60 minutes
Sleep duration
>7hours
6-7 hours
5-6 hours
<5hours
Sleep efficiency
>85%
75-84%
65-74%
<65%
Use of sleep medications
Not in last month
Less than once a week
Once or twice a week
Three or more times a week
Total

Total
(n=113)
N (%)
71 (62.8)

Fallersb
N (%)

Non-fallers
N (%)

p-valuec

39 (73.6)

32 (53.3)

0.0262*
0.6101

35 (31.0)
67 (59.3)
10 (8.8)
1 (0.9)

15 (28.3)
31 (58.5)
6 (11.3)
1 (1.9)

20 (33.3)
36 (60)
4 (6.7)
0
0.1019

42 (37.2)
46 (40.7)
13 (11.5)
12 (10.6)

18 (34.0)
18 (34.0)
8 (15.1)
9 (16.9)

24 (40.0)
28 (46.7)
5 (8.3)
3 (5.0)
0.5621

71 (62.8)
23 (20.4)
8 (7.1)
11 (9.7)

34 (64.1)
9 (17.0)
3 (5.7)
7 (13.2)

37 (61.7)
14 (23.3)
5 (8.3)
4 (6.7)
0.1260

49 (43.4)
25 (22.1)
19 (16.8)
20 (17.7)

20 (37.8)
12 (22.6)
7 (13.2)
14 (26.4)

29 (48.3)
13 (21.7)
12 (20.0)
6 (10)
0.0119*

63 (55.8)
3 (2.7)
5 (4.4)
42 (37.2)
113

24 (45.3)
0
2 (3.8)
27 (50.9)
53

39 (65.0)
3 (5.0)
3 (5.0)
15 (25.0)
60

a. Poor sleep quality=PSQI>5
b. Fallers=Participants who fell down at least once in the past 6 months
c. p-value: Chi-square or fisher’s exact test between fallers and non-fallers and each component of PSQI
*p-value<0.05
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5.4.3 Use of Medications or Treatments to Aid Sleep Outcomes
Sleep medication use was significantly associated with falls (p=0.0352). Among
sleep medication users, 52.0% used a prescription medication, 10.0% used a nonprescription
medication, 12.0% used a herbal products/dietary supplement, 4.0% used alcohol, and 22 %
used multiple medications to aid sleep (8.0% used two types of prescription medications, 10.0%
used prescription medication with nonprescription medication, 2.0% used nonprescription
with herbal, and 2.0% used prescription medication with alcohol). Sleep quality was
associated with sleep medication use (p<0.0001). The prevalence of medications and
treatments used for sleep is shown in Table 5.5.
Table 5.5 Agents Frequently Used for Sleep
Type of Agents
Prescription medications
Nonprescription medications
Herbal products/Dietary supplements
Alcohol

Top Three Most Frequently Used Agents
zolpidem (27.5%), trazodone (22.5%), temazepam
(10.0%), mirtazapine (10.0%), Other (30.0%)
diphenhydramine (41.7%), OTC PM products (33.3%),
doxylamine (16.7%), Other (8.3%)
melatonin (85.7%), sleep aid tea (14.3%)
distilled spirits (66.7%), wine (33.3%)

*Percentages within category and only the top three are listed for each type of agent

5.4.4 Falls Outcomes
The mean FROP-Com score of total participants was 10.81 (SD=4.77). Fallers had
significantly higher scores (i.e., 12.83±5.00), than non-fallers (i.e., 9.03±3.77) (p<0.0001).
According to FROP-Com, the number of falls risk medications, the number of medical
conditions, nocturia, balance difficulties, walking ability in the community, and lower level of
physical activity were significantly associated with falls in the study population.
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Table 5.6 Percentages on Each Risk Factor of Falls Assessed by FROP-Com

Variables

Number of falls in the past 12 months
No falls
1 fall
2 falls
3 or more falls
An injury in any of the falls in the past 12
months
No
Minor injury, did not require medical
attention
Minor injury, did require medical attention
Severe injury
Number of prescription medications
No medication
1-2 medications
3 medications
4 or more medications
Number of falls risk medicationsc
None
1-2 medications
3 medications
4 or more medications
Type of falls risk medications
Sedative
Antidepressant
Anti-epileptic
Central acting analgesic
Digoxin
Diuretics
Type 1a antiarrythmic
Vestibular suppressants
Number of medical conditionsd
None
1-2 conditions
3-4 conditions
5 or more conditions
Type of medical conditions
Arthritis
Respiratory condition
Parkinson’s disease
Diabetes
Dementia
Peripheral neuropathy
Cardiac condition
Stroke
Other neurological conditions
Lower limb amputation

Total N,
(%)

Fallersa
N, (%)

Nonfallers
N (%)

67 (59.3)
31 (27.4)
11 (9.7)
4 (3.5)
(n=46)
24 (52.2)
13 (28.3)
7 (15.2)
2 (4.3)

23 (43.4)
18 (34.0)
8 (15.1)
4 (7.6)
(n=30)
14 (46.7)
8 (26.7)
6 (20.0)
2 (6.6)

44 (73.3)
13 (21.7)
3 (5.0)
0
(n=16)
10 (62.5)
5 (31.3)
1 (6.3)
0

3 (2.7)
15 (13.3)
5 (4.4)
90 (79.7)

1 (1.9)
3 (5.7)
2 (3.8)
47 (88.7)

2 (3.3)
12 (20.0)
3 (5.0)
43 (71.7)

10 (23.0)
53 (61.9)
40 (12.4)
10 (2.7)

6 (11.3)
35 (66.0)
10 (18.9)
2 (3.8)

20 (33.3)
35 (58.3)
4 (6.7)
1 (1.7)

40 (35.4)
32 (28.3)
16 (14.2)
19 (16.8)
4(3.5)
38 (33.6)
0
3 (2.7)

24 (45.28)
21 (39.6)
6 (11.3)
12 (22.6)
0
20 (37.7)
0
2 (3.8)

16 (26.7)
11 (18.3)
10 (16.7)
7 (11.7)
4 (6.7)
18 (30.0)
0
1 (1.7)

10 (8.9)
53 (46.9)
40 (35.4)
10 (8.8)

3 (5.7)
17 (32.1)
29 (54.7)
4 (7.6)

7 (11.7)
36 (60.0)
11 (18.3)
6 (10.0)

85(75.2)
13(11.5)
0
20 (17.7)
0
15 (13.3)
34 (30.1)
10 (8.9)
0
0

42 (79.3)
6 (11.3)
0
13 (24.5)
0
9 (17.0)
20 (37.7)
6 (11.3)
0
0

43 (71.7)
7 (11.7)
0
7 (11.7)
0
6 (10.0)
14 (23.3)
4 (6.7)
0
0

p-valueb

0.0028*

N.A.

0.0936

0.0115*

N.A.

0.0006*

N.A.
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Osteoporosis
Vestibular disorder
Other dizziness
Back pain
Lower limb joint replacement
Vision or somatosensory deficits
None
1 deficit
2 deficits
Foot problems
No
Yes
Inappropriate footwear
No
Yes
Cognitive status
9-10 points
7-8 points
5-6 points
4 or less
Incontinence
No
Yes
Nocturia
No
Yes
Declined food intake in the past three months
No
Small change, but intake remains good
Moderate loss of appetite
Severe loss of appetite/ poor oral intake
Weight loss during the last 3-12 months
None
Minimal (<1 kg) or unsure
Moderate (1-3 kg)
Marked (>3 kg)
Number of alcohol drinks in the past week
None
1-3
4-10
11+
Home environment safety
Yes
Minimal environmental hazards
Moderate environmental hazards requiring
modifications
Extremely unsafe environment
Not able to assess
Observed behaviors in ADL and mobility
indication
Consistently aware of current abilities/seeks
appropriate assistance as required
Generally aware of current

26 (23.0)
2 (1.8)
16 (14.2)
18 (15.9)
28 (24.8)

10 (18.9)
1 (1.9)
10 (18.9)
10 (18.9)
17 (32.1)

16 (26.7)
1 (1.7)
6 (10.0)
8 (13.3)
11 (18.3)

87 (77.0)
25 (22.1)
1 (0.9)

38 (71.7)
14 (26.4)
1 (1.9)

49 (81.7)
11 (18.3)
0

73 (64.6)
40 (35.4)

32 (60.4)
21 (39.6)

41 (68.3)
19 (31.7)

0.3070

0.3775

0.2925
94 (83.2)
19 (16.8)

42 (79.2)
11 (20.8)

52 (86.7)
8 (13.3)

98 (86.7)
15 (13.3)
0
0

45 (84.9)
8 (15.1)
0
0

53 (88.3)
7 (11.7)
0
0

80 (70.8)
33 (29.2)

17 (32.1)
36 (67.9)

44 (73.3)
16 (26.7)

86 (76.1)
27 (23.9)

35 (66.0)
18 (34.0)

51 (85.0)
9 (15.0)

98 (86.7)
14 (12.4)
1 (0.9)
0

44 (83.0)
9 (17.0)
0
0

54 (90.0)
5 (8.3)
1 (1.7)
0

97 (85.8)
13 (11.5)
2 (1.8)
1 (0.9)

44 (83.0)
7 (13.2)
2 (3.8)
0

53 (83.3)
6 (10.0)
0
1 (1.7)

78 (69.0)
19 (16.8)
15 (13.3)
1 (0.9)

39 (73.6)
7 (13.2)
7 (13.2)
0

39 (65.0)
12 (20.0)
8 (13.3)
1 (1.7)

68 (60.2)
13 (11.5)
0
0
32 (28.3)

27 (50.9)
8 (15.1)
0
0
18 (34.0)

41 (68.3)
5 (8.3)
0
0
14 (23.3)

0.7821

0.5280

0.0183*

0.2522

0.3656

0.6838

0.1608

0.8008
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93 (82.3)

43 (81.1)

50 (83.3)

19 (16.8)

10 (18.9)

9 (15.0)

abilities/occasional risk-taking behavior
Under-estimates abilities/inappropriately
fearful of activity
Over-estimates abilities/frequent risk-taking
behavior
Assistance for ADL
None (completely independent)
Supervision
Some assistance required
Completely dependent
Change of ADL after the past fall (n=46)
No
Yes
Assistance for IADL
None (completely independent)
Supervision
Some assistance required
Completely dependent
Change of IADL after the past fall(n=46)
No
Yes
Observation of balance
No unsteadiness observed
Yes, minimally unsteady on walking or
turning
Yes, moderately unsteady on walking or
turning (needs supervision)
Yes, consistently and severely unsteady on
walking or turning (needs constant hands on
assistance)
Waking safely in the house
Independent, no gait aid needed
Independent with a gait aid
Safe with supervision/physical assistance
Unsafe
Walking ability in the community
Independent, no gait aid needed
Independent with a gait aid
Safe with supervision/physical assistance
Unsafe
Aids used (total n=60)
None
Cane
Walker
Cane and Walker
Cane and Scooter
Level of physical activity
Very active (exercises 3 times per week)
Moderately active (exercises less than twice
per week)
Not very active (rarely leaves the house)
Inactive (rarely leaves one room of the house)
Change of physical activity after the past falls
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0

0

0

1 (0.9)

0

1 (1.7)

110 (97.4)
1(0.9)
2 (1.8)
0

50 (94.3)
1 (1.9)
2 (3.8)
0
(n=30)
29 (96.7)
1 (3.3)

60 (100)
0
0
0
(n=16)
16 (100)
0

45 (97.8)
1 (2.2)

29 (54.7)
0
23 (43.4)
1 (1.9)
(n=30)
29 (96.7)
1 (3.3)

33 (55.0)
1 (1.7)
26 (43.3)
0
(n=16)
16 (100)
0

77 (68.1)
35 (31.0)

29 (54.7)
23 (43.4)

48 (80.0)
12 (20.0)

1 (0.9)

1(1.9)

0

0

0

0

88 (77.9)
25 (22.1)
0
0

37 (69.8)
16 (30.2)
0
0

51 (85.0)
9 (15.0)
0
0

55 (48.7)
57 (50.4)
1 (0.9)
0

17 (32.1)
35 (66.0)
1 (1.9)
0

38 (63.3)
22 (36.7)
0
0

21 (18.6)
23 (20.4)
14 (12.4)
2 (1.8)

18 (34.0)
14 (26.4)
11 (20.7)
9 (17.0)
1 (1.9)

35 (58.3)
7 (11.7)
12 (20.0)
5 (8.3)
1 (1.7)

78 (69.0)
27 (23.9)
8 (7.1)
0

31 (58.5)
18 (34.0)
4 (7.5)
0

47 (78.3)
9 (15.0)
2 (6.7)
0

(n=46)

(n=30)

0.1001

45 (97.8)
1 (2.2)

N.A.

0.9168
62 (54.9)
1(0.9)
49 (43.4)
1 (0.9)

N.A.

0.0057*

0.0522

0.0013*

0.0519

0.0497*

N.A.

No
Yes
Total

44 (95.7)
2 (4.3)
113

28 (93.3)
2 (6.7)
53

16 (100)
0
60

a. Fallers=Participants who fell down at least once in the past 6 months
b. p-value=chi-square or fishers’ exact test between falls
c. Falls risk medications: Includes sedatives, antidepressants, anti-epileptics, central acting analgesics, digoxin,
diuretics, type 1a antiarrythmic, and vestibular suppressants
d. Medical conditions: Includes arthritis, respiratory condition, Parkinson ’s disease, diabetes, dementia,
peripheral neuropathy, cardiac condition, stroke, other neurological conditions, lower limb amputation,
osteoporosis, vestibular disorder, other dizziness, back pain, and lower limb joint replacement
*p-value<0.05

In addition, circumstances of all falls during the 6 months were analyzed. Of 109
total falls, 77.1% falls occurred indoors. Participants were asked for reasons for the falls and
34.9% responded loss of balance. Participants required care in emergency departments or
hospitals because of an injury related to the fall in 9.2% of the falls. Only 6.4% of the falls
resulted in change in the medications after the fall.
Table 5.7 Circumstances of Falls
Circumstances

Participants
N (%)

Time of fall
AM
PM
Don’t know
Location of falls
Living room
Kitchen
Bedroom
Bathroom
Community
Outside
Don’t remember
Direction of fall
Sideways
Forward
Backward
Down
Can’t remember
Cause of fall
Trip

39 (35.8)
66 (60.5)
4 (3.7)
32 (29.4)
7 (6.4)
28 (25.7)
15 (13.8)
2 (1.8)
21 (19.3)
4 (3.7)
28 (25.7)
33 (30.3)
11 (10.1)
22 (20.2)
15 (13.7)
22 (20.2)
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Slip
Loss of balance
Knees gave away
Fainted
Feeling dizzy or giddy
Sleepy
Alcohol
Fell out of bed
Back spasm
Unknown
Injury after the fall requiring care in ED or hospital
No
Yes
Change in medications after the fall
No
Yes
Total number of falls

9 (8.3)
38 (34.9)
6 (5.5)
1 (0.9)
9 (8.3)
5 (4.6)
1 (0.9)
3 (2.7)
1 (0.9)
14 (12.8)
99 (90.8)
10 (9.2)
102 (93.6)
7 (6.4)
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5.4.5 Associations between Sleep Medication Use, Sleep Quality, and Falls
Among participants reporting falls, 24.5% reported good sleep quality and no use of
sleep medications, 1.9% reported good sleep quality while using of sleep medications, 20.8%
reported poor sleep quality but no use of sleep medications, and 52.8% reported poor sleep
quality while using sleep medications. Chi-square test showed that all four groups were
significantly related to falls (p=0.0262).
Table 5.8 shows the unadjusted relationship between predictor variables, covariates
and the outcome variable. Except for FROP-Com, no potential confounding variable was
related to the outcome variable. However, all of the covariates were included in the final
model based on previous literature. In the unadjusted model, the risk of falls was significantly
increased among participants with poor sleep quality and sleep medication use compared with
those with good sleep quality and no sleep medication use.
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Table 5.8 Unadjusted Relationships of Predictor Variables, and Covariates to the Outcome
Variable in the Study Sample
Variable

N (%)

Sleep quality
Good sleep quality
Poor sleep quality
Sleep medications
No sleep medication use
Sleep medication use
Sleep quality + Sleep medication use
Good sleep quality + No sleep medications use
Good sleep quality + Sleep medication use
Poor sleep quality + No sleep medication use
Poor sleep quality + Sleep medication use
Age (years)
65-74
75-84
>85
Gender
Male
Female
Race
Caucasian
Other
Marital Status
Married
Other
Education
Less than High School
High School
More than High School
Smoking
Current smoker
Former smoker
Non-smoker (never)
FROP-Com
Mild falls risk
Moderate falls risk
High falls risk
*<0.05
Ref=reference
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Unadjusted OR
(95% CI)

42 (37.2)
71 (62.8)

Ref
2.44* (1.10-5.39)

63 (55.8)
50 (44.2)

Ref
2.24* (1.05-4.79)

36 (31.9)
6 (5.3)
27 (23.9)
44 (38.9)

Ref
0.35 (0.04-3.37)
1.22 (0.44-3.39)
3.01* (1.24-7.74)

30 (26.6)
37 (32.7)
46 (40.7)

Ref
0.67 (0.25-1.76)
0.75 (0.29-1.85)

27 (23.9)
86 (76.1)

Ref
0.52 (0.22-1.25)

89 (78.8)
24 (21.2)

Ref
1.80 (0.72-4.47)

17 (15.0)
96 (85.0)

Ref
1.31 (0.46-3.74)

11 (9.7)
41 (36.3)
61 (54.0)

1.05 (0.29-3.81)
1.32 (0.60-2.93)
Ref

10 (8.9)
48 (42.5)
55 (48.7)

3.25 (0.76-13.9)
1.28 (0.59-2.79)
Ref

71 (62.8)
36 (31.9)
6 (5.3)

Ref
2.89 (1.26-6.62)
>999.999 (<0.001<999.999)

Table 5.9 reports the relationship between poor sleep, sleep medication use,
combination of sleep quality and sleep medication use, and falls. The association was
adjusted for the confounding variables listed in Table 5.1. Compared with participants
reporting good sleep quality and no sleep medication use, those who reported poor sleep
quality and sleep medication use had an increased risk of falls (OR=3.23; 95% CI=1.05-9.91)
after adjusting for covariates. The other two groups did not have a significantly greater risk
for falls compared to participants reporting good sleep quality and no sleep medication use.

Table 5.9 Adjusted Associations between Predictor Variables and the Outcome Variable
Variables
Sleep quality
Good sleep quality
Poor sleep quality
Sleep medications
No sleep medication use
Sleep medication use
Sleep quality + Sleep medication use
Good sleep quality + No sleep medications use
Good sleep quality + Sleep medication use
Poor sleep quality + No sleep medication use
Poor sleep quality + Sleep medication use

N (%)

Adjusted ORa
(95% CI)

42 (37.2)
71 (62.8)

Ref
1.92 (0.76-4.85)

63 (55.8)
50 (44.2)

Ref
2.65 (1.04-6.72)*

36 (31.9)
6 (5.3)
27 (23.9)
44 (38.9)

Ref
0.52 (0.05-5.80)
0.87 (0.27-2.83)
3. 23 (1.05-9.91)*

*<0.05
Ref=reference
a. Full model: Adjusted for age, gender, race, marital status, education, smoking, FROP-Com score

5.4.6 Change in Medication Use and/or Sleep Quality During the Follow-Up Period
After 6 months, one participant in the group of good quality of sleep and sleep medication
use stopped using the medication to aid sleep. In the group of poor sleep quality and no use of
sleep medications, two participants started medications to aid sleep during the follow-up
period. In the group of poor sleep quality and sleep medication use, six participants stopped
using medications or treatment for sleep, and two participants had an important change in
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sleep efficiency during the follow-up period of 6 months. Among sleep medication users, five
participants either changed to a different medication or treatment to aid sleep or added
additional medications or treatments to aid sleep during the follow-up period.

5.5 Discussion
5.5.1 Falls in Community-Dwelling Older Adults
The results of the prospective cohort study of community-dwelling older adults
showed that 46.9% fell at least once and 23.9% fell more than once during the 6 months. The
prevalence was higher than what is commonly reported (i.e., approximately 30% of older
adults aged 65 years or older for at least one fall and 50% among those aged 80 years or older
for at least one fall in community settings per year).45 The results were more surprising
considering the duration of the current study which was only 6 months, however, the majority
of participants were 85 years or older. Older adults who chose or need to live in retirement
communities may be more frail or have more functional limitations than those who live
independently in their own homes. More falls were reported possibility secondary to having a
standardized definition of falls and collecting the falls meticulously by using multiple
methods.
Number of falls risk medications, number of medical conditions, nocturia, balance,
walking ability in the community, and level of physical activity were significantly associated
with falls in FROP-Com. These risk factors, except for nocturia, were included in the
AGS/BGS guideline when assessing the fall risk (an evidence-based practice guideline).46
However, some studies have reported that nocturia is associated with falls in communitydwelling older adults.132,133
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This study described the circumstances of falls in community-dwelling older adults,
including time, location, direction, and cause. In this study, 77.1% of the falls occurred
indoors which was higher than previous studies that reported 12-65% of indoor falls.134–136
This could be related to the living environment where residents do not have to go outside to
access many services. Falls occurred mostly in the living rooms and bedrooms. The
prevalence of 9.2% injurious falls requiring medical attention was similar to another
prospective cohort study with a 6-month follow-up period that reported approximately 10%
of community-dwelling older adults being admitted to the hospital after a fall.137 The majority
of the fallers did not change their medications after the falls. For those who had a medication
adjustment, pain medications or muscle relaxants were added.
There are various fall risk assessment tools used in assessing community-dwelling
older adults. A literature review that evaluated fall risk assessment tools in older adults in
different settings recommended using the Timed Up & Go (TUG) and Functional Gait
Assessment (FGA) in community-dwelling older adults.138 The TUG has a specificity of 96.6%
and a sensitivity of 83.3% when using a cutoff score of greater than or equal to 12.34
seconds.138,139 The FGA has a sensitivity of 100% and a specificity of 83% when using a
cutoff score of less than or equal to 22/30.138,139 Compared to these tools, the FROP-Com has
lower sensitivity of 67.1% and specificity of 66.7%.123,138 However, the TUG and FGA are
single task performance measures that are more targeted on balance and gait features.
Although the sensitivity and specificity are high, it is possible that important information for
designing interventions is not collected in these measures.61 FROP-Com was selected in this
study because it was a more comprehensive fall risk assessment that asks about multiple
factors related to risk of falls in older adults. Use of multiple-task performance measures may
provide more detailed information to understand the multiple risk factors related to falls in
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older adults.61 Moreover, it was chosen because of its applicability in community settings.
There are several methods to document the occurrence of falls (i.e., distributing postcard calendars, making telephone calls or conducting face-to-face interviews).140–143 A
monthly fall diary was used in this study. Advantages of the fall diary include less chance for
recall bias than the methods requiring recollection over longer time intervals, and less burden
to participants compared with using post-cards that ask participants to mail them at the end of
each month. Diaries were checked monthly by the researcher during the follow-up meetings
or calls. Some of the disadvantages could be that a participant may forget to record falls for
the whole month on the monthly diary, and it could be less precise on collecting falls than
weekly calls to the participants. However, considering the difficulties of contacting the
participants weekly by telephone calls, and the possibility of more lost to follow-ups by
asking the participants to send the post-card diaries, the use of monthly fall diaries was
relatively convenient for the researcher and the participants. Since the falls diary was shown
to be more precise in collecting falls than retrospective recall over different time periods,144 it
is possible that using monthly fall diaries impacted the number of falls in this study.

5.5.2 Poor Sleep Quality and Medication Use to Aid Sleep in Community-Dwelling Older
Adults
Sleep quality was assessed by using the PSQI. The PSQI is a valid instrument that
measures sleep disturbances compared with an objective instrument such as
polysomnography (PSG)14,145. The PSQI include important aspects of sleep disturbance.122
However, most authors of studies that have assessed the association between poor sleep and
falls have formulated their own questions to evaluate sleep problems. Fallers had a
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significantly higher mean PSQI global score than non-fallers in our study.
In this study 68.2% of the participants reported poor sleep quality, however, this rate
may have been influenced by the recruitment plan. Those who had poorer quality of sleep
than others might be more likely to participate in the study. Also, 44.2% of older adults used
medications or treatments to aid sleep. Those who were concerned that participation might
threaten their access to sleep medications might be less likely to participate in the study. This
is related to barriers to participate because falls, sleep, and sleep medication use are sensitive
issues in many older adults.
There may be bias when those who participate in the study are different from those
who do not participate in the study, and characteristics of older adults who did not participate
in this study were not identified. In addition, as the second stage of recruitment, older adults
who used any type of agents for sleep problems were specifically recruited and selection bias
could have occurred during this process. Selection bias can lead to under-represented or overrepresented of certain members of the general population that may challenge the external
validity of the study. Thus, as one of the steps to minimize the effects of selection bias,
subjects were recruited from multiple study sites including three different congregate senior
housing with different demographic and socioeconomic characteristics.
In addition, 22% of sleep medication users took multiple sleep aids, and 40% used
potentially inappropriate OTC products and alcohol for sleep. The updated Beers criteria
were used to determine potentially inappropriate medications.146 According to the Beers
criteria, diphenhydramine and doxylamine are recommended to be avoided in older adults.146
In one study of older adults, 30.6% used OTC sleep aids such as Tylenol PM® and 13.0%
drank alcohol to treat sleep complaints.147 Half of those who used OTC sleep aids or alcohol
did not consult with their healthcare provider about their sleep problems.147 In another study,
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about 70% of older women treated their sleep problems with OTC medication and alcohol.148
These results suggest that sleep problems are frequently treated by older adults themselves
rather than by the doctors. Moreover, since there is the possibility of under-reporting of
alcohol use in this age group,149 it is possible that more older adults could have used alcohol
for poor sleep in this study than was reported.
In reality, use of sleep medications or sleep quality is dynamic. Unlike crosssectional database studies based on surveys at a single point in time, changes in the usage of
sleep medications and sleep efficiency could be observed during the follow-up period. Sleep
efficiency was documented instead of sleep quality during the follow up period because of
the burden to the participants of administering the PSQI each month. Thus, this study was
able to document the change among the four groups over 6 months. Ten participants (8.8%)
either had a change in sleep medication use (i.e., started or stopped a medication for sleep) or
in sleep efficiency (i.e., an increase from <65% of efficiency to >85% or the other way) after
6 months from the baseline assessments.

5.5.3 Associations between Sleep Medication Use, Poor Sleep Quality, and Falls
In this study, community-dwelling older adults with poor sleep quality were more
likely to experience a fall (OR=2.87; 95% CI=1.21-6.78). However, after adjusting for
covariates, the association was not significant. Poor sleep quality could lead to falls by
causing daytime sleepiness and reduced psychomotor performance,40 but the association was
mitigated after adjusting for other covariates that are associated with falls. On the contrary,
the risk of falls was found in older adults who used medications to aid sleep in unadjusted
association (OR=2.24; 95% CI=1.05-4.79) and in adjusted association (OR=2.65; 95%
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CI=1.04-6.72). This confirms the results of the past systematic literature reviews that showed
an increased risk of falls with the use of psychotropic drugs (i.e., sedative hypnotics,
benzodiazepines, and antidepressants). In this current study, 52.0% of sleep medication users
took prescription medications. The four medications that were most frequently used were
zolpidem, trazodone, temazepam, and mirtazapine. Several studies have shown that zolpidem
increases risk in falls in adults aged 18 years or older150 and older adults.72,73
Risk of falls was compared among the four groups: 1) poor sleep quality and no sleep
medication use, 2) good sleep quality and sleep medication use, 3) poor sleep quality and
sleep medication use, and 4) good sleep quality and no sleep medication use. In unadjusted
associations, only the group of older adults who had poor sleep quality and used medications
for sleep had a significant increase in the risk of falls (OR=3.01; 95% CI=1.24-7.74)
compared with the group with good sleep quality and no use of sleep medications. After
adjusting for covariates, the risk was slightly increased (OR=3.23; 95% CI=1.05-9.91).
Whether or not adjusting for other confounding variables, a significant risk of falls was seen
in the group with sleep medication use and poor sleep quality. This shows that continued poor
sleep quality while taking sleep medications results in higher risk of falls than either one
alone. Risk of falling increases as the number of risk factors increases.151,152
The group of older adults with poor sleep quality and no use of sleep medication had
no significantly greater risk for falls. The impact of untreated sleep problems on risk of falls
may not be as important a problem for community-dwelling older adults. This is consistent
with the results of the current study that found a lack of association between poor sleep
quality and falls after adjusting for covariates. Similarly, the group of older adults with good
sleep quality and sleep medication use had no significantly greater risk for falls. Older adults
in this group would mean that their poor sleep quality is well treated with the medications,
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thus having a protective effect on falls. This raises the question of whether medication
effectiveness is important to consider in understanding the risk of falls for those who use
medications or treatments to aid sleep. However, because of the relatively low number of
participants in this particular group results must be interpreted with caution.
Still, the results of the study suggest that when poor sleep quality is observed, sleep
medication use had an impact on the risk of falls. It may be that the effectiveness of sleep
medications is essential to consider when assessing the risk of falls. Perhaps, sleep
medication use may have protective effect on risk of falls only when poor sleep is well
treated.
In this prospective cohort study, four groups based on poor sleep quality and sleep
medication use were formed to better understand whether use of sleep medications, poor
sleep quality, both, or neither contribute to risk of falls in older adults. However, there were
relatively fewer participants in the group of good sleep quality and use of sleep medications
as previously mentioned. This could be because of several reasons. First, it could be a
consequence of the effectiveness of medications. Although older adults take medications or
treatments for sleep, it is still questionable how effective these agents are for improving sleep
because no randomized-controlled study has assessed the effectiveness of the long-term usage
of sedative hypnotics in the older adult population. Secondly, if the medications for sleep
work well in older adults, it is less likely that individuals would participate in the study
because of a fear of changes in their normal medication regimens or daily lives. Thirdly, this
could just be a results of the conservative score criteria for the PSQI used in this study. From
a score of 0 to 21, a score of more than 5 indicates poor sleep quality. There are seven
components in the PSQI and one of them is use of sleep medication. The score is 0 if the
respondents did not use any medications or treatments for sleep in the past month, 1 if taken
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less than once a week, 2 if taken once or twice a week, and 3 if taken three or more times a
week. Thus, the respondents already scored 3 out of 21, if they use any medications for sleep.
Since there was no collinearity among the variables, the sleep medication component
in the PSQI will less likely affect the results. If the sleep medication component is deleted in
the survey, 31.8% (n=14) of older adults in the group of those with poor sleep quality and
sleep medication use, were redefined as those with good sleep quality and sleep medication
use with the same scoring criteria. However, since the validity and reliability of the PSQI was
evaluated with all seven components of the survey, not considering one component will affect
its’ validity and reliability. In addition, a different modeling method using the interaction term
of sleep quality and sleep medication was conducted, but the results were unchanged.

5.5.4 Strengths and Limitations
Some strengths of this study may be noted. The standardized definition of the
outcome falls provided from the WHO was used. Using the standardized definition of the
outcome ensured more consistent ascertainment of the outcome and applied the same
definition across all participants. Most studies have not included a definition of falls. In the
current study, when participants called the researcher to report a fall, the researcher asked
several questions derived from the standardized definition to ascertain the fall. This helped to
reduce the misclassification bias because the perception of falls varies among people, as some
consider it to be a fall only when they fall all the way to the ground or suffer injuries from
falls. Moreover, fall diaries were used to collect the outcome. Participants were asked to put a
check mark at the end of each week if they had not fallen during the prior week and this
helped to reduce recall bias. For monthly follow-up meetings, participants either met every
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month or were contacted by phone to determine whether the outcome had occurred. Since
participants may forget to report the outcome or forget whether they had an outcome after a
long period of time, this helped to reduce the recall bias as well.
There were advantages related to the design of the study. Studies with the outcome of
interest being falls have been mostly retrospective in design. Since this was a prospective
study, the researcher had more control over the nature and the content of the data collected to
answer the research question. This 6-month prospective study collected information on
medications that were prescribed for or used by older adults to aid sleep in detail, especially
information on sleep aids such as herbals, dietary supplements, and alcohol used for sleep in
older adults that is rarely found in retrospective studies. In addition, there is lack of
information on poor sleep quality in administrative claims, large federally funded survey
databases, and medication records. By using a validated questionnaire, it was possible to
measure sleep quality. Also, it was possible to collect information on the specific
circumstances of the falls (e.g., time, location, and possible causes). Since the outcome was
followed prospectively, there may have been less recall bias in remembering the events
compared with retrospective studies. Only three participants were lost to follow-up after 6
months. The researcher was able to track participants who went to the hospital because of an
injury from a fall with the help of neighbors and friends. Therefore, it is suggested that there
was less bias in the results because of the severity of the falls or fear of reporting a fall.
Moreover, a prospective study in design is better at evaluating cause-effect relationships
compared with a retrospective study.
During the monthly contacts participants were asked whether they had made any
changes in the usage of medications for sleep compared to the regimen from the baseline
assessments. They were asked whether they have started any new medications for sleep or
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stopped taking medications. Few questions about sleep were asked in the monthly meetings
to assess whether there were any changes in sleep efficiency compared to the baseline
assessments. Retrospective studies typically assess the exposure variables only during the
baseline assessments. Thus, any changes in the groups over the 6 month follow up period
were possible to detect in this study.
This was the only known study to evaluate the association between poor sleep quality,
sleep medication use, and falls in community-dwelling adults aged 65 years or above. There
was one study that evaluated the association between insomnia, hypnotic use, and falls in
older adults residing in nursing homes that found greater risk of falls in those with insomnia
but no use of hypnotics, and in those with insomnia and use of hypnotics compared with
those with no insomnia and no use of hypnotics.40
There are some limitations of this study. The aim of the study was to find the
association in community-dwelling older adults and included older adults residing in three
independent senior housing with residents of different socioeconomic and demographic status.
However, a majority of the participants in this study were white females and 40% of the total
participants were 85 years or older. Thus, the results may not be entirely generalizable to
other older adult groups.
In addition, all the information that was collected was self-reported that may lead to
misclassification bias. Any type of medications or treatments that were used for sleep was
collected by conducting medication reviews. Participants either brought the actual
medications that they took within the past month or showed medical prescriptions during the
interview. However, participants might have not reported the agents they took for sleep
because they forgot to report or reported the agents differently from the agents that they
actually took. In addition, indications of medications were solely determined based on the
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verbal confirmation of the participants. Because most of the indications of the medications
were self-reported, it is possible that there were errors in the reporting and the medications
were actually intended to be used for different purposes. For example, mirtazapine was
reported to be either used for sleep or depression leading to different categorization of the
participants, however, this type of potential miscategorization affected only a few participants.
On the contrary, self-reporting of the indication of the medications has enabled us to capture
the variety of the medications or treatments that patients claim that they were using to aid
sleep.
Information on medication dose was not accounted for in the analysis. For example,
the Drug Burden Index (DBI), a measure of exposure to anticholinergic and sedative
medications that considers dosage was not calculated.153 However, this study found that nine
of the participants used 10 mg of zolpidem for sleep problems once daily before bedtime used
more than the recommended dose in geriatric patients.
Furthermore, the PSQI was used to assess poor sleep quality among participants. It is
a self-reported method that is more subjective compared with using actinography or medical
diagnosis. However, the procedures of assessments using the survey were the same across the
participants by following a script and by having only two researchers administering the study
during the study. The outcome of falls was also self-reported. Fall diaries were distributed
and monthly contacts to the participants were conducted, however there could still be
participants who might have forgotten to report the outcome.
Lastly, the total number of the participants in this study was less than in most
retrospective studies that used large databases or medical records. Although multiple
recruitment strategies were performed, it is possible that some older adults were concerned
about participating in a research study generally or because they might receive some
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unwanted treatments or disadvantages from participating. Retention of the participants was
also crucial in this study. Three participants (2.6%) from the group of poor sleep quality and
no sleep medication use were lost to follow-up. Although it was a small percentage, their falls
could have affected the results of the study considering the total number of participants.

5.6 Conclusion
This study explored the independent effect of poor sleep quality, sleep medication use,
and their combined effect on the risk of falls. Older adults with poor sleep quality and sleep
medication use had a significantly the higher risk of falls compared with those with good
sleep quality and no sleep medication use. Poor sleep quality in spite of sleep medication use
has increased the risk of falls. In other words, the combined effect of poor sleep quality and
sleep medication use increased the risk of falls more than the individual effects alone. More
prospective studies are needed to confirm the results of this study.
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Chapter 6
Conclusion and Future Research

6.1 Conclusion
The research underlying this dissertation focused on the association between
medications used for sleep, poor sleep, and falls in community-dwelling older adults. The
cross-sectional database study assessed the prevalence of sleep problems, sleep medication
use, and falls in older adults. Having sleep problems was significantly associated with a risk
of falls compared with not having sleep problems. Older adults were grouped by sleep
problems and use of sleep medication. The risk was seen in all the groups compared to those
with no sleep problems and no sleep medication use. The highest risk was found in older
adults with no sleep problems and sleep medication use that may suggest that sleep
medication use did not have a protective effect on risk of falls.
The prospective cohort study showed that poor sleep quality did not predict a
significantly higher risk for future falls, while use of sleep medications predicted a higher risk.
When compared with older adults with good sleep quality and no use of sleep medications,
the risk of falls was only found in older adults who had poor sleep quality and use of sleep
medications after controlling for covariates. The risk was not found in the other two groups: 1)
older adults with good sleep quality and sleep medication use, and 2) those with poor sleep
quality with no sleep medication use.
Possible reasons for the difference in findings between the cross-sectional study and
the prospective cohort study would be the difference in the study design and measurement of
study variables.
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In conclusion, the results of the both studies suggest that poor sleep added to sleep
medication use increased the risk of falls in community-dwelling older adults. The research
undertaken in this dissertation provided evidence for a significant risk of falls associated with
the combined effect of poor sleep and sleep mediation use.
It is important to consider medication-associated risk when treating sleep problems in
older adults. Since older adults with poor sleep quality in spite of sleep medication use have
greater risk of falls, it further suggests that medication effectiveness may be an important
factor to consider in understanding the risk of falls associated with medications agents used
for sleep. Health care professionals should assess the effects of sleep medication use on poor
sleep quality to achieve better health outcomes. This study filled a gap in the current literature
by untangling confounding by indication of poor sleep quality, sleep medication use, and falls
in community-dwelling older adults.

6.2 Future Research
Future investigators should consider conducting this study with a larger sample size.
Future studies may include more independent senior housings communities with a longer
recruitment period to accomplish this. With a larger sample size, the risk of falls in older
adults with no sleep problems and use of medications or treatments for sleep could be
confirmed.
Additionally, a subgroup analysis could be performed between the types of
medications or even among different therapeutic classes to further compare the risk of falls.
This would enable clarification of the inconsistent results on the association between some
commonly used agents for sleep and falls in this population.
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Lastly, survival analysis could be conducted to assess the cumulative risk of falls
because a history of a fall is one of the risk factors for future falls. Further analyses on the
risk of recurrent falls and injurious falls in prospective studies would be valuable.
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Appendix A
Search Algorithms for the Systematic Review of the Association between Poor Sleep and
Falls in Community-Dwelling Older Adults

Pubmed/Medline
The search algorithms combined three domains: (Sleep OR sleep problems) AND Falls.
1. sleep[MeSH]
2. sleep[Text Word]
3. sleep disorders[MeSH]
4. sleep disorders[Text Word]
5. 1 or 2 or 3 or 4
6. accidental falls[Mesh]
7. falls[Text Word]
8. 6 or 7
9. 5 and 8
("Sleep"[Mesh] OR "sleep disorders"[Mesh] OR “sleep”[tw] OR “sleep disorders”[tw]) AND
("accidental falls"[Mesh] OR “falls”[tw])

CINAHL
(MH "Sleep+") OR "sleep" OR (MH "sleep disorders+") OR "sleep disorders"
AND (MH "accidental falls") OR "falls"

PsyINFO
Any Field: ((IndexTerms:("Falls" )) OR Subject:("accidental falls" OR "falls") AND
PublicationYear:[0 TO 2013] ) AND Any Field: ((IndexTerms:("Hypersomnia") OR
IndexTerms:("Insomnia") OR IndexTerms:("Kleine Levin Syndrome") OR
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IndexTerms:("NREM Sleep") OR IndexTerms:("Napping") OR IndexTerms:("Narcolepsy")
OR IndexTerms:("Parasomnias") OR IndexTerms:("REM Sleep") OR IndexTerms:("Sleep")
OR IndexTerms:("Sleep Disorders") OR IndexTerms:("Sleepwalking" )) OR
Subject:("Hypersomnia" OR "Insomnia" OR "Kleine Levin Syndrome" OR "NREM Sleep"
OR "Napping" OR "Narcolepsy" OR "Parasomnias" OR "REM Sleep" OR "Sleep" OR
"Sleep Disorders" OR "Sleepwalking" ) AND PublicationYear:[0 TO 2013] )
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Appendix B
Research Subject Information and Consent Form
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Appendix C
Study Advertisement Flyer
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Apendix D
Study Brochure
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Appendix E
Subject ID:
Date:
Basic Demographics
1. What is your age?
2. Gender
o Male
o Female
3. What is your race?
o White
o Black or African-American
o American Indian or Alaska Native
o Asian
o Native Hawaiian or Other Pacific Islander
4. What is your highest level of education?
o Less than High School
o High School graduate/GED
o Associate’s degree
o Bachelor’s degree
o Advanced degree
5. Do you smoke or have you smoked?
o

I have never smoked before

o

I used to smoke
 How many years ago did you quit?
 How many years did you smoke?
 On average, how many packs-per-day did you smoke?

o

I currently smoke
 How many years have you been smoking?
 On average, how many packs-per-day do you smoke?
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Appendix F
Subject ID:
Date:
Medication Review

What type of prescription medications have you used within the past month?
PRESCRIPTION MEDICATION
Name

Strength
(Dose)

Indication
What do you take the
medication for?

Frequency
How many times a day
do you take the
medication?

What type of nonprescription medications have you used within the past month? Nonprescription
medications are medications that can be bought from over the counter without a prescription from
your doctor. And have you used any herbal aids or dietary supplements such as vitamins within the
past month?
NONPRESCRIPTION MEDICATION/HERBAL AIDS/DIETARY SUPPLEMENTS
Name

Strength
(Dose)

Indication

142

Frequency

Appendix G
Subject ID:
Date:
Questions about Alcohol Intake for Sleep
1. Have you used alcohol in the past week?

Yes/No

2. Have you used alcohol in the past month?

Yes/No

→If answered “Yes”, continue asking the following questions. If answered “No”, stop asking.
3. Have you used alcohol to help you sleep in the past month? Yes/No
→If answered “No”, ask again, “you haven’t used any beer or wine to help you fall asleep?”
4. Which alcohol have you used for sleep problems in the past month?
→Circle the option based on the answers.
Beer
Wine
Sherry
Distilled Spirits (whiskey, gin, tequila, rum, vodka, or other distilled spirits)
Other

5A. Thinking about your past month, about how many days per week did you use alcohol to help you
sleep?
1) 6-7 times a week
2) 4-5 times a week
3) 2-3 times a week
4) Once a week
5) Less than once a week (on special occasions)
5B. During those days, on average, how many drinks did you have per day?
(A ‘standard’ drink is equal to 12 ounces of regular beer, 5 ounces of table wine, or 1.5 ounces of hard
liquor/spirits)
1) 5 or more drinks
2) 3-4 drinks
3) 1-2 drinks
4) Less than one drink
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Appendix H

Subject ID:
Date:
The Functional Comorbidity Index (FCI)
Circle the specific disease and calculate the total score.
Do you have any of the following conditions?
1.
2.
3.
4.

9.
10.

Arthritis (rheumatoid and osteoarthritis)
Osteoporosis
Asthma
Chronic obstructive pulmonary disease (COPD), acquired respiratory distress syndrome
(ARDS), or emphysema
Angina
Congestive heart failure (or heart disease)
Heart attack (myocardial infarct)
Neurological disease (such as multiple sclerosis or Parkinson’s or other neurological
conditions:
)
Stroke or TIA
Peripheral vascular disease or Peripheral neuropathy

11.
12.
13.
14.
15.
16.
17.

Diabetes types I and II
Upper gastrointestinal disease (ulcer, hernia, reflux)
Depression
Anxiety or panic disorders
Visual impairment (such as cataracts, glaucoma, macular degeneration)
Hearing impairment (very hard of hearing, even with hearing aids)
Degenerative disc disease (back disease, spinal stenosis, or severe chronic back pain)

18.

Obesity and/or body mass index > 30 (weight in kg/height in meters2)
height_____________________(cm or inches?)
weight_____________________(kg or lbs?) BMI=
Vestibular disorder
Other dizziness
Lower limb amputation
Lower limb joint replacement

5.
6.
7.
8.

19.
20.
21.
22.

Total score (number of check marks from #1-18):
(Abbreviations: TIA= transient ischemic attack)

Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index with physical
function as the outcome. J Clin Epidemiol. 2005 Jun;58(6):595-602.
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Appendix I
Subject ID:
Date:

Monthly Follow-Up Questions
Following questions will be asked by the researcher to the participants verbally.
A Question for Subjective Sleep Quality
1. During the past month, what time have you usually gone bed at night?
2. During the past month, what time have you usually gotten up in the morning?
3. During the past month, how many hours of actual sleep did you get at night? (This may be different
than the number of hours you spent in bed.)
4. During the past month, how would you rate your sleep quality overall?
1) Very good
2) Fairly Good
3) Fairly bad
4) Very bad

Questions for Treatments to Aid Sleep
1. Are you still taking

(refer to the medication for sleep) that you reported last month? Yes/No

→If No, skip #2.
2. Did you change the dosage or frequency of
Yes/No

that you reported last month?

→ Remind the dosage and frequency that were reported last month. If ‘yes’, what dosage are you
taking now and how many times a day do you take the medication?
→ Proceed to #3.
3. Have you started taking any new medications for sleep or switched to a different medication for
sleep from what you have reported last month? Yes/No
→If ‘yes’ ask the name, dosage and frequency of intake.
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Fall Questionnaire
These questions will also be asked during the monthly meetings in case the participant did not call the
researcher within 48hours after a fall.
1. Did you have a fall in the past month? Yes/No
2. Did you fall more than once in the past month? Yes/No

Ask question As if the person fell only once and ask question Bs if the person fell more than once.
3A. Was it intentional? Yes/No
3B. Among any of the falls, were any of those intentional? Yes/No (Record them as first, second fall
and so on)

4A. Did you touch the ground floor or other lower level when you fell? Yes/No
4B. Among any of the falls, did you touch the ground floor or other lower level when you fell?
Yes/No (Record them as first, second fall and so on)

5A. Can you please describe the circumstances of the recent fall?
5B. Can you please describe the circumstances of all the falls? (→Time, location, and whether they
think they have a reason for the fall).

6A. Did you make any changes in medications before or after the fall? Yes/No
6B. Among any of the falls, did you make any changes in medications before or after the falls?
Yes/No (→If answered ‘yes’, please describe.)
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Appendix J
The Fall Diary

June 2013
Sun

Mon

Tue

Wed

Thu

Fri

Sat
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30
Notes: Jun 16: Father’s Day
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Appendix K
Subject ID:
Date:
Fall Questionnaire
These questions will be asked when the participant calls the researcher to report a fall.

1. Did you fall on ___day? Yes/No
(→If the participant told the researcher that he/she had a fall on a particular day, double
check with this question)

2. Was it intentional? Yes/No

3. Did you touch the ground floor or other lower level when you fell? Yes/No

4. Can you please describe the circumstances of the recent fall?
(→Time, location, and whether they think they have a reason for the fall).

5. Did you make any changes in medications before or after the fall? Yes/No
(→If answered ‘yes’, please describe.)
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